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Summary 
BreastScreen Australia aims to reduce illness and death resulting from breast cancer through 
organised screening to detect cases of unsuspected breast cancer in women, thus enabling 
early intervention. BreastScreen Australia targets women aged 50–69 for free 2-yearly 
screening mammograms. 
This report is the latest in the BreastScreen Australia monitoring report series, which is 
published annually to provide regular monitoring of national participation and performance 
for BreastScreen Australia. The report provides data for the 2010–2011 period of participation 
in BreastScreen Australia, as well as the latest available data on breast cancer incidence 
(2009) and mortality (2010).  
The following statistics refer to the latest data available for women aged 50–69. 
How many women were diagnosed with, or died from, breast cancer? 
In 2009, there were 7,022 new cases of invasive breast cancer diagnosed in Australian women 
aged 50–69. This is equivalent to 288 new cases per 100,000 women.  
Breast cancer incidence has remained steady at around 290 per 100,000 women since 2003.  
In 2010, a total of 1,098 women aged 50–69 died from breast cancer, equivalent to 43 deaths 
per 100,000 women. This makes breast cancer the second most common cause of 
cancer-related death for Australian women after lung cancer. 
Breast cancer mortality decreased from 68 to 43 per 100,000 women between 1991 (when 
BreastScreen Australia began) and 2010. This has been attributed to the early detection of 
cancers through BreastScreen Australia, along with advances in management and treatment. 
How many women participated in BreastScreen Australia? 
In 2010 and 2011, more than 1.3 million women aged 50–69 had a screening mammogram 
through BreastScreen Australia. This was 55% of women in the target age group. 
Lower participation occurred in Very remote areas, among Indigenous women, and among 
women who reported that they speak a language other than English at home. 
While participation increased with improving socioeconomic status, this trend was small, 
with all socioeconomic groups recording participation rates between 53% and 55%. 
The difference between Aboriginal and Torres Strait Islander and non-Indigenous women 
was greater, with 36% of Aboriginal and Torres Strait Islander women having a screening 
mammogram in 2010–2011, compared with 54% of non-Indigenous women. 
How many women were recalled for further investigation? 
In 2011, 11% of women screening for the first time were recalled for further investigation;  
4% of women attending subsequent screens were recalled. 
How many women had a small breast cancer detected? 
Small breast cancers (≤15 mm in diameter) are associated with better treatment options and 
improved survival. A high proportion of invasive breast cancers detected were small in 2011: 
50% of invasive breast cancers detected in those attending their first screen, and 63% in those 
attending subsequent screens. 
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Data at a glance 
The following summary table provides a ‘snapshot’ of the latest national data for 
BreastScreen Australia against key performance indicators for women in the target age 
group, 50–69 years. Summary statistics for the previous and the latest reporting periods are 
presented, along with the relevant standard from the BreastScreen Australia National 
Accreditation Standards (NAS), which provides a benchmark for the data shown.  
Definitions for the performance indicators are given under each indicator in Section 2. 
Key performance indicators for BreastScreen Australia, women aged 50–69 
  Previous data
(b)
  Latest data Change 
Performance indicator NAS
(a)
 Reporting period Statistic  Reporting period Statistic  
Participation >70% 2009–2010 55.0  2010–2011 54.6 
 
Rescreening       
 
After first screening round >75% 2008 59.9  2009 59.4  
After second screening round >90% 2008 71.2  2009 69.8  
After third and subsequent 
screening rounds >90% 2008 81.6 
 
2009 82.3  
Recall to assessment        
First screening round <10% 2010 11.1  2011 10.7  
Subsequent screening rounds <5% 2010 4.2  2011 3.8  
Invasive breast cancer detection   
   
 
After first screening round >50 2010 91.6  2011 82.1  
After second screening round >35 2010 44.4  2011 42.9  
Small-size cancer detection >25 2010 29.2  2011 28.4  
Ductal carcinoma in situ detection   
   
 
After first screening round ≥12 2010 17.9  2011 20.9  
After second screening round ≥7 2010 11.5  2011 11.2  
Invasive breast cancer 
incidence . . 2008 295.3 
 
 
2009 
 
288.2 
 
 
Mortality . . 2009 46.0 
 
2010 43.3  
(a)  The NAS were developed by the National Quality Management Committee and represent minimum standards that represent the ability of 
an individual BreastScreen service to meet the aims and objectives of BreastScreen Australia. The NAS are used as benchmarks for these 
data only, since this is a different purpose to that for which these standards were developed, and differences in definitions or data may 
exist. 
(b)  For the BreastScreen Australia monitoring report 2009–2010, New South Wales data for rescreening, recall to assessment, invasive breast 
cancer detection, ductal carcinoma in situ (DCIS) detection, and sensitivity were not available. This report presents these missing data as 
well as the latest data. 
Notes  
1. All rates are for women aged 50–69 and are age-standardised. 
2. Participation is the percentage of screened women in the population.  
3. Rescreening is the percentage of women who rescreen within 27 months. 
4. Recall to assessment is the percentage of women screened who are recalled for further investigation. 
5. Invasive breast cancer detection and DCIS detection data are the number of women diagnosed per 10,000 women screened. 
6. Invasive breast cancer incidence is the number of new cases per 100,000 women.  
7. Mortality is the number of deaths from invasive breast cancer per 100,000 women.  
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Section 1 Introduction 
This report 
The first section of this report presents an overview of breast cancer in Australia; it also 
outlines the process of breast cancer screening, and describes the development and 
management of BreastScreen Australia. As well, it details the performance indicators used 
for monitoring the program, and provides a brief summary of technical issues that should be 
considered when interpreting information in this report. 
The second section of this report presents the latest national data against the eight 
BreastScreen Australia performance indicators. Each performance indicator section starts 
with a summary that includes a definition of the performance indicator and its rationale; this 
is followed by key results indicating the main findings. More detailed analyses, as well as 
background information where appropriate, follow this summary material.  
More detailed data than those shown in this report are available in the BreastScreen Australia 
monitoring report 2010–2011: supplementary data tables. These tables can be downloaded for 
free from the AIHW website <www.aihw.gov.au/publications>.  
The BreastScreen Australia monitoring report 2010–2011 is part of an annual series. Earlier 
editions and any published subsequently can be downloaded for free from the AIHW 
website <http://www.aihw.gov.au/publications>. The website also includes information on 
ordering printed copies. 
 
Anatomy: The breast and adjacent lymph nodes 
© National Cancer Institute, 2013. 
Source: <http://visualsonline.cancer.gov>. 
Reproduced with permission of the copyright owner. 
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Overview 
What is breast cancer? 
Breast cancer occurs when abnormal cells grow and multiply out of control. Breast cancer 
most commonly originates in the ducts of the breast (which carry milk from the lobules to 
the nipple) but can also originate in the lobules (small lobes of the breast that produce milk). 
For more information on breast cancer see the Cancer Australia website 
<www.canceraustralia.gov.au>. 
How common is breast cancer in Australia? 
Breast cancer is the most common cancer affecting Australian women (excluding basal and 
squamous cell carcinoma of the skin). In 2009, 13,668 new cases were diagnosed, or 113.5 
new cases per 100,000 women. It is the second most common cause of cancer mortality in 
Australian women after lung cancer, with 2,840 deaths, or 21.6 deaths per 100,000 women, in 
2010. 
Aboriginal and Torres Strait Islander women have lower rates of breast cancer diagnosed 
than their non-Indigenous counterparts (82.1 and 103.6 new cases per 100,000 women in 
2004–2008, respectively). Despite this, death rates do not differ between Aboriginal and 
Torres Strait Islander and non-Indigenous women (for more details see indicators 7a and 8). 
Men can also develop breast cancer, but women are about 100 times more likely to develop 
the disease. Breast cancer in men is not covered in this report.  
What is ductal carcinoma in situ? 
Ductal carcinoma in situ (DCIS) is a non-invasive tumour arising from the milk ducts. The 
changes to the cells lining the milk ducts seen in DCIS are similar to those for invasive 
breast cancer. However, unlike invasive breast cancer, DCIS does not invade the 
surrounding breast tissue; instead, it is contained entirely within the milk duct.  
Although the precise relationship between DCIS and invasive breast cancer remains 
unclear, there is general consensus that DCIS represents an intermediate step between 
normal breast tissue and invasive breast cancer (Virnig et al. 2010).  
There are other types of carcinoma in situ of the breast, such as lobular carcinoma in situ 
(also known as LCIS), which begins in the milk-making glands (lobules). LCIS is not a true 
cancer or pre-cancer but is a risk factor for invasive breast cancer, as is age or having a 
family history of breast cancer (American Cancer Society 2011; Cancer Australia 2009).  
What are the known risk factors for breast cancer? 
Many risk factors, both established and probable, have been identified for breast cancer in 
women. Age is the biggest risk factor in developing breast cancer, with most breast cancers 
occurring in women over the age of 50. A family history of breast cancer can also increase a 
woman’s risk, although most women who develop breast cancer do not have a family history 
of the disease. Other factors that may increase a woman’s risk of developing breast cancer 
include not having carried or given birth to any children, late age at birth of first child, early 
menstruation and late menopause. Oral contraception use can cause a small increase in the 
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risk of breast cancer, as can hormone replacement therapy, which causes an increase in risk 
consistent with late menopause (De et al. 2010; McPherson et al. 2000). 
Family history of breast cancer 
Women are considered to have about twice the risk of breast cancer if they have a 
first-degree relative (mother, sister or daughter) diagnosed with breast cancer before the age 
of 50 (McPherson et al. 2000). The more relatives a woman has with breast cancer—and the 
younger they are when they develop the disease—the higher is the risk to the woman of 
developing breast cancer. Other factors increasing risk include a family history of bilateral 
breast cancer, breast cancer before the age of 40 and male breast cancer (NBCC 2006).  
Genetic predisposition accounts for up to 10% of breast cancers in Western countries 
(McPherson et al. 2000). Harmful mutations in two identified breast cancer genes, called 
BRCA1 and BRCA2, are involved in many cases of hereditary breast cancer, and a woman’s 
risk of developing breast cancer is greatly increased if she inherits a harmful BRCA1 or 
BRCA2 mutation (McPherson et al. 2000). 
How do we screen for breast cancer? 
Mammography (X-ray of the breast) is the test used in breast cancer screening. In screening 
mammography, two views are taken of each breast, and the images are reviewed by 
radiologists to look for suspicious characteristics that require further investigation. Screening 
mammography, like the screening tests used in other programs such as bowel and cervical 
screening, is not intended to be diagnostic; rather, it aims to identify people who are more 
likely to have breast cancer, and therefore require further investigation from diagnostic tests. 
In contrast to screening mammography, diagnostic mammography targets a specific area of 
the breast using multiple views, which makes it appropriate for women with symptoms that 
may indicate the presence of breast cancer. 
Why screen for breast cancer? 
Organised breast cancer screening aims to detect cases of unsuspected breast cancer in 
women, thus enabling intervention when the cancer is at an early stage. Finding breast 
cancer early often means that the cancer is small, which is associated with increased 
treatment options (NBOCC 2009) and improved survival (AIHW & NBCC 2007). 
Twenty-eight per cent (28%) of the breast cancers detected outside BreastScreen Australia are 
small; in comparison, 61% of breast cancers detected by BreastScreen Australia are small. As 
well, treatment of breast cancers detected by BreastScreen Australia is more likely to be 
breast-conserving surgery (74% compared with 56% outside the program) (NBOCC 2009), 
which is associated with decreased morbidity. 
Further, it was recently estimated that 8.8 and 5.7 breast cancer deaths were prevented per 
1,000 women screened using data from the Swedish Two-Country Trial and England’s breast 
cancer screening program, respectively (Duffy et al. 2010), and a recent evaluation of 
BreastScreen Australia estimated that breast cancer mortality has been reduced by 21–28% 
(BreastScreen Australia EAC 2009a). 
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How is breast cancer screening managed in Australia? 
Australia’s national breast cancer screening program was established in 1991 as the National 
Program for the Early Detection of Breast Cancer. This program is now known as 
BreastScreen Australia, and is a joint program of the Australian and state and territory 
governments. BreastScreen Australia aims to reduce mortality and morbidity from breast 
cancer. A list of its aims and objectives is presented in the box on the following page. 
BreastScreen Australia provides free biennial breast cancer screening to women through 
dedicated screening and assessment services. Women have a screening mammogram 
performed at a screening unit (which may be fixed, relocatable or mobile). Women whose 
images are suspicious for breast cancer are recalled for further investigation by a 
multidisciplinary team at an assessment centre. Further investigation may include clinical 
examination, mammography, ultrasound and biopsy procedures. Most women who are 
recalled for assessment are found not to have breast cancer.  
Who is eligible to participate in BreastScreen Australia? 
BreastScreen Australia actively invites women aged 50–69 to have free biennial breast cancer 
screening. Women aged 40–49 and 70 or over are also eligible to attend. Women aged 50–69 
are targeted because they have a relatively high incidence of breast cancer, and screening 
mammography is known to be effective in reducing mortality in this age group 
(BreastScreen Australia 2004). Screening mammography is less effective in women aged 
under 50 because of biological differences in the breast tissue of pre-menopausal women. 
This results in more investigations and missed breast cancers (false negative results) due to 
the lower sensitivity of screening mammography in this age group (Irwig et al. 1997).  
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Aims and objectives of BreastScreen Australia 
Aims 
 To ensure that the program is implemented in such a way that statistically significant 
 reductions can be achieved in morbidity and mortality attributable to breast cancer. 
 To maximise the early detection of breast cancer in the target population. 
 To ensure that screening for breast cancer in Australia is provided in dedicated and 
 accredited screening and assessment services as part of the BreastScreen Australia Program. 
 To ensure equitable access for women aged 50−69 years to the program. 
 To ensure that services are acceptable and appropriate to the needs of the eligible 
 population. 
 To achieve high standards of program management, service delivery, monitoring and 
 evaluation, and accountability. 
Objectives  
 To achieve a 70 per cent participation rate in the BreastScreen Australia Program by women 
 in the target group (50–69) and access to the program for women aged 40–49 years and  
 70–79 years.  
 To rescreen all women in the program at two-yearly intervals.  
 To achieve agreed performance outcomes which minimise recall rates, retake images, 
 invasive procedures, ‘false negatives’ and ‘false positives’, and maximise the number of 
 cancers detected, particularly the number of small cancers.  
 To refer to appropriate treatment services and collect information about the outcome of 
 treatment.  
 To fund, through state coordination units, screening and assessment services which are 
 accredited according to agreed National Accreditation Standards and to ensure that those 
 standards are monitored and reviewed by appropriate national and state and territory 
 accreditation committees.  
 To recognise the real costs to women of participation in the program and to minimise those 
 costs. This includes the provision of services at minimal or no charge, and free to eligible 
 women who would not attend if there was a charge.  
 To make information about mammographic screening and the BreastScreen Australia 
 program available in a variety of easily comprehensible and appropriate forms, to women 
 and health-care providers in particular.  
 To achieve patterns of participation in the program which are representative of the 
 socioeconomic, ethnic and cultural profiles of the target population.  
 To provide services in accessible, non-threatening and comfortable environments by staff 
 with appropriate expertise, experience and training.  
 To provide appropriate service in that: the provision of counselling, education and 
 information is an integral part of the program; sensitive procedures for notification of recall
  are in place; and the time between the initial screen and assessment is minimised.  
 To achieve high levels of participation in the development and management of the program 
 by members of significant professional and client groups.  
 To collect and analyse data sufficient to monitor the implementation of the program, to 
 evaluate its effectiveness and efficiency and to provide the basis for future policy and 
 program development decisions (BreastScreen Australia 2004). 
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How is BreastScreen Australia monitored? 
Performance indicators 
The performance of a population-based cancer screening program such as BreastScreen 
Australia needs to be assessed as it relates to the underlying aims of the program. At the 
national level, this is achieved by reporting data against a series of performance indicators to 
allow screening outcomes to be monitored, and positive and negative trends identified early.  
BreastScreen Australia has been monitored since 1996–1997 using performance indicators 
developed and endorsed by the former National Screening Information Advisory Group and 
by jurisdictional BreastScreen programs. These national performance indicators represent 
key measures of the progress BreastScreen Australia is making towards reducing morbidity 
and mortality from breast cancer; they are listed in the table below. 
BreastScreen Australia performance indicators 
1 Participation The percentage of women aged 50–69 who have a screening 
mammogram through BreastScreen Australia in a 2-year period 
2 Rescreening The proportion of women screened who return for a rescreen within 
27 months 
3 Recall to assessment  The proportion of women screened who are recalled for further 
investigation 
4 Invasive breast cancer detection The number of women with invasive breast cancer detected through 
BreastScreen Australia 
5 Ductal carcinoma in situ detection  The number of women with DCIS detected through BreastScreen 
Australia 
6 Sensitivity The ability of screening mammography to successfully detect cancers 
 6a Interval cancers  
 6b Program sensitivity  
7 Incidence The number of new cases of invasive breast cancer or DCIS  
 7a Invasive breast cancer incidence  
 7b Ductal carcinoma in situ incidence  
8 Mortality The number of deaths from invasive breast cancer 
Accreditation standards 
The NAS were developed by the National Quality Management Committee for accreditation 
of individual BreastScreen services. The NAS represent minimum standards to measure a 
service’s performance against the aims and objectives of BreastScreen Australia (BreastScreen 
Australia 2004).  
A number of NAS are consistent with the performance indicators in this report. For this 
reason, where appropriate, the data in this report are benchmarked against the NAS. These 
benchmarks are useful in helping to interpret the data presented, since the NAS were not 
designed to be used as standards for the BreastScreen Australia performance indicators. 
See <www.cancerscreening.gov.au> for further information about BreastScreen Australia. 
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Data 
Data sources 
The main sources of data for performance indicators are the state and territory BreastScreen 
registers. Analyses of these data allow monitoring of participation, rescreening, recall to 
assessment, detection of invasive breast cancer, detection of DCIS, and sensitivity (Indicators 
1 to 6). State and territory BreastScreen registers are ‘live’ registers. As such, the data in this 
report can be viewed as accurately describing the data held by the registers only at a 
particular moment in time, since any results or clinical information received by the 
BreastScreen registers after data are provided to the Australian Institute of Health and 
Welfare (AIHW) are unable to be captured. Data in this report can be considered accurate as 
at December 2012. 
Additional to these sources are the AIHW Australian Cancer Database, which is the source of 
breast cancer incidence data (Indicator 7a); the state and territory cancer registries, which are 
the source of DCIS incidence data (Indicator 7b); and the National Mortality Database, which 
is the source of breast cancer mortality data (Indicator 8). More detail on these data sources 
and classifications is provided at Appendix C.  
Note that for each performance indicator, the latest available national data are used, which 
differ depending on both the data source and specifications of each performance indicator. 
New South Wales data available for all performance indicators 
Last year, New South Wales data for participation by main language spoken at home  
(a disaggregation of participation), rescreening, recall to assessment, invasive breast cancer 
detection, DCIS detection, and sensitivity were not available for 2009–2010. This was due to 
issues related to implementing a new business information system in New South Wales. 
Where New South Wales data were not included, a total for the other states and territories 
was provided. 
This report presents these New South Wales data for 2009–2010 as well as the latest data for 
2010–2011, with the exception that New South Wales data were not available for interval 
cancers and program sensitivity for women screened in 2008 with 13–24 months follow-up.  
Aboriginal and Torres Strait Islander women 
Of the performance indicators used to monitor BreastScreen Australia, participation, 
incidence and mortality are disaggregated by Indigenous status. 
Women who attend for a screening mammogram at a BreastScreen Australia service are 
asked to complete a form that includes personal and demographic details, as well as 
personal and family history of breast cancer. The form also contains a question on 
Indigenous status, where women can identify as being ‘Aboriginal’, ‘Torres Strait Islander’, 
‘both Aboriginal and Torres Strait Islander’, or ‘neither Aboriginal nor Torres Strait Islander’. 
This information is recorded by the state and territory BreastScreen registers, with the 
responses aggregated into the categories of ‘Aboriginal and Torres Strait Islander’ and 
‘non-Indigenous’, with a third ‘not stated’ category for women who choose not to answer 
this question (see Appendix B for data definitions and quality concerns).  
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Other performance indicators based on BreastScreen register data are not routinely 
disaggregated by Indigenous status due to concerns about stability and comparability of 
rates from small numbers. However, further data on Aboriginal and Torres Strait Islander 
women can be found in more detailed analyses of BreastScreen Australia performance 
indicators conducted to inform the BreastScreen Australia Evaluation (BreastScreen 
Australia EAC 2009b).  
Reporting women with symptoms 
In principle, women who have symptoms that could indicate the presence of invasive breast 
cancer or DCIS (such as a lump, or clear or bloody discharge from the nipple) at the time of a 
breast cancer screen should be excluded from all performance indicators reported, since 
these women are more likely to have a breast cancer or DCIS detected by the screening 
process. However, the management policy of women with symptoms is not uniform across 
states and territories, with some women with symptoms screened. Therefore, in practice, 
data in this report include that for both symptomatic and asymptomatic women.  
Terminology and concepts 
Reporting periods 
This report presents monitoring data in 1-year, 2-year, 3-year and 5-year reporting periods.  
• Most data are presented over a 1-year period, including rescreening, recall to 
assessment, detection of invasive breast cancer, detection of DCIS, and invasive breast 
cancer incidence and mortality. 
• Participation data are presented in a 2-year reporting period in line with the 
recommended 2-year screening interval of BreastScreen Australia.  
• Sensitivity data are presented in a 3-year reporting period. A 5-year reporting period is 
used when invasive breast cancer incidence and mortality data are disaggregated into 
different population groups. A 5-year reporting period is also used for DCIS incidence. 
These 3- and 5-year reporting periods are used to improve stability and comparability of 
rates due to small numbers. 
Age groups 
Data are presented for women aged 50–69 who, as the target age group of BreastScreen 
Australia, are actively invited to participate in the program. Where appropriate, data are also 
presented for women aged 40–49 and 70 and over, who are also eligible to have free 
screening mammograms through BreastScreen Australia. More detailed data for these age 
groups can be accessed in the BreastScreen Australia monitoring report 2010–2011: 
supplementary data tables. 
Crude versus age-standardised 
This report presents crude and age-standardised rates. Crude is the ‘true’ proportion or rate, 
and is appropriate when a single year or reporting period is reported (for example, crude 
participation in 2010–2011 was 55.0%). However, comparisons over time, or across 
states/territories or population subgroups require that crude rates are age-standardised to 
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remove the underlying differences in age structure over time or between groups. These 
allow analyses of trends and differentials, and are therefore preferentially reported in these 
situations (for example, participation in 2010–2011, age-standardised using the Australian 
population in 2001, was 54.6%). 
Confidence intervals 
Confidence intervals are presented in this report only where it has been deemed important to 
show the degree of error due to rare events in small populations; this is done to avoid 
potential misinterpretation of data and/or to present data consistent with other publications. 
This includes breast cancer and DCIS detection, interval cancers, incidence of breast cancer 
and DCIS, and mortality from breast cancer. 
Where shown, 95% confidence intervals can be used to determine if a statistically significant 
difference exists between compared values: where the confidence intervals do not overlap, 
the difference between rates is greater than that which could be explained by chance and is 
regarded as statistically significant. Because overlapping confidence intervals do not imply 
that the difference between two rates is definitely due to chance, it can be stated only that no 
statistically significant differences were found, and not that no differences exist.  
Judgment should be exercised in deciding whether or not any differences shown are of 
clinical significance.  
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Section 2 Performance indicators 
Indicator 1 Participation 
What you need to know about participation 
Definition: The percentage of women aged 50–69 screened through BreastScreen Australia 
in a 2-year period.  
Rationale: BreastScreen Australia aims to maximise the early detection of breast cancer in the 
target population, women aged 50–69. High attendance for screening by women in this age 
group maximises the reductions in mortality from breast cancer (BreastScreen Australia 
2004). The NAS recommend that at least 70% of women aged 50–69 participate in screening 
in the most recent 24–month period (NAS 1.1.1) (BreastScreen Australia 2004). 
Guide to interpretation: Participation is measured over 2 years to align with the 
recommended screening interval of BreastScreen Australia. Participation is based on the 
number of women screened, not the number of screening mammograms performed. 
Data are presented for women aged 50–69 (the target age group), as well as for women aged 
40–49 and 70 and over where appropriate. No attempt has been made to adjust the 
population for women who have previously had breast cancer and are therefore not eligible 
for breast cancer screening through BreastScreen Australia. It should be noted that states and 
territories have different policies on screening women who have previously been diagnosed 
with breast cancer. 
The most recent participation data are for the 2010–2011 reporting period. 
What the data tell us about participation 
 Trend 
Participation has remained steady, between 55% and 57%, for most years from 1996–1997, 
when reporting began, to 2010–2011, despite a steady increase in the number of women 
participating over this time. 
The age-standardised participation rate was 54.6% in 2010–2011 which was similar to that in 
2008–2009, at 55.2%. 
 
2010–2011 
In 2010–2011, a total of 1,726,099 women participated in BreastScreen Australia, of whom 
1,373,731 (79.6%) were aged 50–69. This is 55.0% of women in the target age group which, 
when age-standardised to allow analyses of trends, equates to a participation rate of 54.6%. 
While participation progressively increased with improving socioeconomic status, this 
trend was small, with participation ranging between 53.1% and 54.9%. 
Participation was lower for Aboriginal and Torres Strait Islander women (36.2%) than for 
non-Indigenous women (53.9%). 
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Detailed analyses 
Participation in 2010–2011 
In 2010–2011, 1,726,099 women participated in BreastScreen Australia (that is, they had at 
least one screening mammogram over the 2 years), of whom 1,373,731 were aged 50–69. 
These 1,373,731 women represent 55.0% of women in the target age group which, when  
age-standardised to allow analysis of trends and differentials, equates to a participation rate 
of 54.6%. 
Although the NAS for participation has not been met at the national level (NAS 1.1.1 being 
that at least 70% of women aged 50–69 participate in screening in the most recent 24–month period), 
a reduction in breast cancer mortality has been observed with the current participation rate 
of around 55%. 
Participation trends 
Table 1.1 shows the trend in participation nationally, from 1996–1997, when reporting began, 
to 2010–2011, for which the most recent national data are available. 
Table 1.1: Number and age-standardised rate of women aged 50–69 participating in BreastScreen 
Australia, 1996–1997 to 2010–2011 
Reporting period Participants
(a) 
Population
(b) 
AS rate
(c) 
1996–1997 845,143 1,645,331 51.5 
1997–1998 927,735 1,700,951 54.6 
1998–1999 976,182 1,754,254 55.7 
1999–2000 1,012,184 1,809,735 55.9 
2000–2001 1,064,246 1,868,832 57.0 
2001–2002 1,102,642 1,928,878 57.1 
2002–2003 1,118,823 1,989,802 56.2 
2003–2004 1,145,008 2,051,480 55.7 
2004–2005 1,188,955 2,114,036 56.1 
2005–2006 1,242,210 2,177,660 56.9 
2006–2007 1,262,334 2,242,133 56.1 
2007–2008 1,273,317 2,308,680 54.9 
2008–2009 1,319,771 2,376,559 55.2 
2009–2010 1,352,112 2,444,680 55.0 
2010–2011 1,373,731 2,497,963 54.6 
(a) Participants are the number of women screened through BreastScreen Australia in each 2-year reporting period. The screening periods 
cover 1 January of the initial year to 31 December of the latter year indicated. 
(b) Population is the average of the Australian Bureau of Statistics (ABS) estimated resident population for women aged 50–69 for the 
2 reporting years. 
(c) Age-standardised (AS) rate is the number of women aged 50–69 screened in each 2-year reporting period as a percentage of the ABS 
estimated resident population for women aged 50–69, age-standardised to the Australian population at 30 June 2001. 
Source: AIHW analysis of BreastScreen Australia data. 
The age-standardised rate of participation for women aged 50–69 was 51.5% in 1996–1997 
when reporting began. This increased to a peak of 57.1% in 2001–2002 and thereafter 
remained steady at about 56% before decreasing slightly to about 55% from 2007–2008. In 
2010–2011, the age-standardised rate of participation was 54.6% (Table 1.1). 
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Participation by age 
In 2010–2011, the proportion of women screened was highest in women aged 50–69, in line 
with aim of BreastScreen Australia to maximise the proportion of women in the target age 
group who are screened every 2 years. Further, the proportion of women participating was 
equal to or above 49.3% for all 5-year age groups within the target age group, peaking at 
59.1% in women aged 60–64 (Figure 1.1). 
The proportion of women screened outside the target age group dropped away steeply, with 
13.8% of women aged 40–49 and 11.5% of women aged 70 and over screening in 2010–2011, 
compared with 55.0% of women aged 50–69 (all crude rates) (Figure 1.1). 
 
Note: The data for this graph are in BreastScreen Australia monitoring report 2010–2011: supplementary data tables. 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 1.1: BreastScreen Australia participation by age group, females, 2010–2011 
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The breakdown of women screened into the age groups 40–49, 50–69 and 70 and over is 
shown in Figure 1.2 for the reporting periods 2000–2001 and 2010–2011.  
Between 2000–2001 and 2010–2011, women in the target age group have comprised an 
increasing proportion of all women screened, from 67.9% in 2000–2001 to 79.6% in  
2010–2011. Concurrent to this has been a decrease in the 40–49 age group from 18.4% to 
12.6% and in the 70 and over age group from 13.8% to 7.8% (Figure 1.2). 
A B B 
  
Source: AIHW analysis of BreastScreen Australia data. 
Figure 1.2: Age distribution of women aged 40 or over screened by BreastScreen 
Australia, 2000–2001 (A) and 2010–2011 (B) 
Participation by state and territory 
In 2010–2011, participation across all states and territories was within 12.7 percentage points 
of the national average of 54.6%, ranging from 41.9% to 58.1% (Table 1.2; Figure 1.3).  
Table 1.2: BreastScreen Australia participation by state and territory, women aged 50–69, 2010–2011 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 Number 419,012 340,286 285,886 146,271 116,040 37,706 20,342 8,188 1,373,731 
 AS rate 50.9 55.1 57.6 57.7 58.1 57.2 52.1 41.9 54.6 
Notes 
1. Participants are the number of women screened through BreastScreen Australia in each 2-year reporting period. The screening periods 
cover 1 January of the initial year to 31 December of the latter year indicated. 
2. Rates are the number of women screened as a percentage of the eligible female population, calculated as the average of the ABS’s 
estimated resident population and age-standardised to the Australian population at 30 June 2001. 
3. Direct comparisons between the states and territories of Australia are not advised due to the substantial differences that exist between the 
jurisdictions including for population, geographic size and structure, policies and other factors. 
Source: AIHW analysis of BreastScreen Australia data. 
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Source: AIHW analysis of BreastScreen Australia data. 
Figure 1.3: BreastScreen Australia participation by state and territory, women aged 50–69, 
2010–2011 
Participation by remoteness area 
In 2010–2011, participation was highest in Outer regional areas (58.5%), and lowest in Very 
remote areas (45.8%) (Table 1.3; Figure 1.4A).  
To improve access for women in Remote and Very remote locations, states and territories use 
relocatable screening services, mobile screening vans and community buses to overcome 
transport barriers. A 4-wheel drive digital mobile screening service—a first of its kind—was 
introduced in 2010, providing better access to BreastScreen Australia for women in isolated 
and hard-to-reach locations in Queensland.  
Table 1.3: BreastScreen Australia participation by remoteness area, women aged 50–69, 2010–2011 
 Major cities Inner regional Outer regional Remote Very remote Australia 
Number 888,605 316,160 143,482 18,256 6,824 1,373.731 
AS rate 53.2 57.2 58.5 55.2 45.8 54.6 
Notes 
1. Rates are the number of women screened as a percentage of the eligible female population calculated as the average of the ABS’s 
estimated resident population and age-standardised to the Australian population at 30 June 2001. Period covers 1 January 2010 to  
31 December 2011. 
2. Remoteness areas were assigned using the woman’s residential postcode according to the Australian Standard Geographical Classification 
for 2006. Not all postcodes can be assigned to a remoteness area therefore, categories do not add to Australia.  
Source: AIHW analysis of BreastScreen Australia data. 
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Participation by socioeconomic status 
There was little variation in participation across socioeconomic groups, with all groups 
having participation rates between 53.1% and 54.9%. There was a slight trend of increasing 
participation with increasing socioeconomic status (Figure 1.4B; Table 1.4).  
 
Table 1.4: BreastScreen Australia participation by socioeconomic status, women aged 50–69,  
2010–2011 
 1 (Lowest) 2 3 4 5 (Highest) Australia 
Number 263,735 284,354 273,906 268,655 277,917 1,373,731 
AS rate 53.1 54.8 54.7 54.9 54.4 54.6 
Notes 
1. Rates are the number of women screened as a percentage of the eligible female population calculated as the average of the ABS’s 
estimated resident population and age-standardised to the Australian population at 30 June 2001. Period covers 1 January 2010 to  
31 December 2011. 
2. Socioeconomic status was assigned using the woman’s residential postcode according to the Socioeconomic Index for Areas (SEIFA) Index 
of Relative Socioeconomic Disadvantage for 2006; 1 (lowest socioeconomic group) corresponds to the most disadvantaged socioeconomic 
status and 5 (highest socioeconomic group) to the least disadvantaged socioeconomic status. Not all postcodes could be assigned to a 
socioeconomic category, therefore, categories do not add to Australia. 
Source: AIHW analysis of BreastScreen Australia data. 
Participation by Indigenous status  
Aboriginal and Torres Strait Islander women participate in BreastScreen Australia at a lower 
rate than non-Indigenous women.  
In 2010–2011, the participation rate of Aboriginal and Torres Strait Islander women aged 
50–69 was 36.2% compared with that for non-Indigenous women of 53.9%—a difference of 
17.7 percentage points (Table 1.5). 
Many of the state and territory BreastScreen programs have developed, and continue to 
develop, strategies and initiatives to encourage greater participation by Aboriginal and 
Torres Strait Islander women. These strategies and initiatives are based on research to ensure 
A 
 
B  
 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 1.4: BreastScreen Australia participation by remoteness area (A) and by socioeconomic  
status (B), women aged 50–69, 2010–2011 
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that they are sensitive and appropriate to the knowledge, attitudes and beliefs of Aboriginal 
and Torres Strait Islander women (see, for example, BreastScreen SA 2003; BreastScreen WA 
2008). 
Strategies to encourage participation include dedicated and appropriate communication 
resources, and block and group bookings. BreastScreen programs also liaise closely with 
Aboriginal Health Workers and Aboriginal and Torres Strait Islander community groups to 
increase acceptance of screening. 
Table 1.5: BreastScreen Australia participation by Indigenous status, women aged 50–69, 2010–2011 
(a) Includes women in the ‘not stated’ category for Indigenous status. Therefore, columns may not sum to the Australia column. 
Notes 
1. Limitations of Aboriginal and Torres Strait Islander data are detailed at Appendix B. 
2. Rates are the number of women screened as a percentage of the eligible female population calculated as the average of the ABS’s 
estimated resident population and age-standardised to the Australian population at 30 June 2001. The screening periods cover 1 January of 
the initial year to 31 December of the latter year indicated. 
Source: AIHW analysis of BreastScreen Australia data. 
Participation by main language spoken at home 
In 2010–2011, the difference in participation between English-speaking women (55.8%) and 
those who reported that they speak a language other than English at home (47.3%) was 
8.5 percentage points (Table 1.6). 
Table 1.6: BreastScreen Australia participation by main language spoken at home, women aged  
50–69, 2010–2011 
(a) Includes women in the ‘not stated’ category for main language other than English spoken at home. Therefore, columns may not sum to the 
Australia column. Data may differ from that published in the BreastScreen Australia monitoring report 2009–2010 due to updates to the 
database. 
Notes 
1. Some jurisdictions do not use the ‘not stated’ category, and there may also be differences in how these data are collected. This means that 
the analysis based on main language spoken at home should be interpreted with caution. Limitations are detailed at Appendix B. 
2. Rates are the number of women screened as a percentage of the eligible female population calculated as the average of the ABS’s 
estimated resident population and age-standardised to the Australian population at 30 June 2001. The screening periods cover 1 January of 
the initial year to 31 December of the latter year indicated. 
Source: AIHW analysis of BreastScreen Australia data. 
  
 Aboriginal and Torres Strait Islander Non-Indigenous Australia
(a)
 
 Number 11,971  1,341,869  1,373,731  
 AS rate 36.2  53.9  54.6  
 English-speaking Non-English-speaking Australia
(a) 
Number  1,174,236  193,812  1,373,731 
AS rate 55.8 47.3 54.6 
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Indicator 2 Rescreening 
What you need to know about rescreening 
Definition: The proportion of women screened in a given year, whose screening outcome 
was a recommendation to return for screening in 2 years, and who returned for a screen 
within 27 months. 
Rationale: A high rescreen rate is important to increase the likelihood of breast cancers being 
detected early and to maintain overall participation. The NAS for rescreening require that at 
least 75% of women aged 50–67 who attend for their first screen are rescreened within 
27 months (NAS 1.2.1). The NAS also recommend that at least 90% of women aged 50–67 
who attend for their second and subsequent screens are rescreened within 27 months 
(NAS 1.2.2) (BreastScreen Australia 2004). 
Guide to interpretation: The screening interval of 27 months is used instead of the 
recommended screening interval of 2 years to allow for potential delays in screening 
availability and data transfer.  
Note that although the BreastScreen Australia target age group is 50–69, only women aged 
50–67 are reported for the rescreen rate because women aged 68–69 in the index year will be 
outside the target age group 27 months after their index screen.  
The denominator (the number of women screened in each index year) has not been adjusted 
to remove women who died or developed an interval cancer after their screen in the index 
year and therefore would not go on to rescreen. 
The most recent rescreening data are for women screened in the index year 2008 and 2009. 
This small lag in data availability is because 27 months needs to have passed since a 
woman’s last screen to know whether or not she has rescreened within this interval. 
What the data tell us about rescreening 
 Trend 
There was very little difference between rescreening after a screen in 2008 compared with 
rescreening after a screen in 2009, regardless of the screening round. 
 
Women rescreening after a screen in 2008  
The proportion of women aged 50–67 who screened in 2008 and rescreened within  
27 months ranged from 59.9% after the first screening round and 71.2% after the second 
screening round to 81.6% after the third and subsequent screening rounds. 
Women rescreening after a screen in 2009 
The proportion of women aged 50–67 who screened in 2009 and rescreened within  
27 months ranged from 59.4% after the first screening round and 69.8% after the second 
screening round to 82.3% after the third and subsequent screening rounds. 
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More information about rescreening 
The rescreening indicator measures the proportion of women who return for screening at a 
BreastScreen service within the recommended interval. The interval between screens is an 
important factor influencing the level of cancer detection. BreastScreen Australia national 
policy states that women should be screened every 2 years. It has been shown that screening 
intervals longer than 2 years reduce mortality benefits from screening and result in an 
increase in interval cancers (BreastScreen Australia 2004). This is because increased time 
between screening may allow a tumour to grow to the point where symptoms become 
evident, thus eliminating the advantage of screening. 
Box 2.1: Terminology 
Screening round: the first screening round is a woman’s first visit to a mammography 
screening service; a subsequent screening round is any visit to a mammography screening 
service after this first visit (that is, a subsequent screening round means that she has been 
screened before). 
Detailed analyses 
Rescreening after a screen in 2008 and 2009 
The proportion of women aged 50–67 who returned for a rescreen within 27 months 
increased with the number of screens or ‘screening rounds’ (see Box 2.1) previously attended 
(Figure 2.1; only 2008 data are shown in Figure 2.1).  
 
Note: Rates are the number of women rescreening within 27 months as a percentage of women screened and age-standardised to  
the population of women attending a BreastScreen service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 2.1: Rescreen rate for women screened in 2009, aged 50–67, by screening round  
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The proportion of women aged 50–67 who were screened in 2008 and returned within 
27 months increased from 59.9% after the first screening round and 71.2% after the second 
screening round to 81.6% after the third and subsequent screening rounds.  
The data for 2009 show a similar trend, with 59.4% of women aged 50–67 returning within 
27 months after the first screening round, 69.8% returning after the second screening round, 
and 82.3% after the third and subsequent screening rounds (Figure 2.1). 
The NAS for rescreening have not been met at the national level for 2008 and 2009 (NAS 1.2.1 
being that at least 75% of women aged 50–67 who attend for their first screening round are 
rescreened within 27 months, and NAS 1.2.2 being that at least 90% of women aged 50–67 who 
attend for their second and subsequent screens are rescreened within 27 months). 
Rescreening by age in 2008 and 2009 
In 2008 and 2009, the highest rescreen rates were for women aged 50–67, followed by women 
aged 40–49 in all three screening rounds. Women aged 70 and over had far lower rescreen 
rates regardless of the screening round (Figure 2.2). 
 
Note: Rates are the number of women rescreening within 27 months as a percentage of women screened and 
age-standardised to the population of women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 2.2: Rescreen rate for women by age and screening round, screened during 2009 
In 2008, as screening round increased, women aged 50–67 comprised a greater proportion of 
women rescreening—63.8% of those attending their first screen, 74.3% of those attending 
their second screen and 84.0% of those attending their third or subsequent screen (see 
BreastScreen Australia monitoring report 2010–2011: supplementary data tables). 
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The same trend was also seen in 2009 with women aged 50–67 comprising 64.8% of those 
attending their first screen, 74.0% of those attending their second screen and 84.0% of those 
attending their third or subsequent screen (see BreastScreen Australia monitoring report 
2010–2011 supplementary data tables).  
Rescreening by state and territory in 2008 and 2009 
In 2008 and 2009, although there was some variation among the data for states and 
territories, all mirrored the national trend of increasing rescreen rates with increased number 
of screens previously attended (Table 2.1).  
Table 2.1: Rescreen rate for women aged 50–67, screened during 2008 and 2009 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2008 
First screening round 
AS rate 60.7 52.2 62.6 61.8 64.9 71.9 49.2 52.2 59.9 
Second screening round 
AS rate 73.8 63.8 71.3 69.0 66.5 78.3 61.4 66.1 71.2 
Third and subsequent  
screening rounds  
AS rate 80.0 77.8 85.6 84.2 82.4 88.5 74.4 80.2 81.6 
 2009 
First screening round 
AS rate 59.0 59.8 59.9 62.0 63.6 67.9 32.8 54.5 59.4 
Second screening round 
AS rate 70.4 67.3 70.3 70.7 68.8 73.3 43.1 70.2 69.8 
Third and subsequent 
screening rounds 
AS rate 79.4 83.7 84.6 85.2 83.2 86.1 62.8 82.7 82.3 
Note: Rates are the number of women rescreening within 27 months as a percentage of women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 3 Recall to assessment 
What you need to know about assessment 
Definition: The proportion of women screened in a given year who are recalled for 
assessment. 
Rationale: Women are recalled to assessment for further investigation if their screening 
mammogram is found to be suspicious for breast cancer. BreastScreen Australia aims to 
maximise the number of cancers detected while minimising the number of unnecessary 
investigations. Recall to assessment can cause anxiety as a result of uncertainty and the 
requirement to undergo additional procedures. The NAS recommend that less than 10% of 
women aged 50–69 who attend for their first screen are recalled for assessment (NAS 2.6.1), 
and that less than 5% of women aged 50–69 who attend for their second or subsequent screen 
are recalled for assessment (NAS 2.6.2) (BreastScreen Australia 2004). 
Guide to interpretation: Recall to assessment is disaggregated into first and subsequent 
screening rounds because a woman is more likely to be recalled to assessment the first time 
she visits a BreastScreen service than at subsequent visits. This is for two reasons: firstly, a 
woman is more likely to have an invasive breast cancer detected on her first visit; secondly, 
with no previous images with which to compare her first screening mammography images, 
it is more difficult to distinguish between what is normal and what might be suspicious 
(BreastScreen WA 2008). 
Changes to recall to assessment rates should be considered alongside corresponding invasive 
cancer detection rates, as a higher recall to assessment rate may be considered acceptable if it 
leads to higher breast cancer detection rates. 
The most recent recall to assessment data are for women screened in 2010 and 2011. 
What the data tell us about recall to assessment 
 Trend 
Recall to assessment decreased only slightly between 2010 and 2011, from 11.1% to 10.7% 
for the first screening round and from 4.2% to 3.8% for subsequent screening rounds. 
 
Women screened in 2010 
For women aged 50–69, 11.1% of women screened for the first time were recalled to 
assessment, while 4.2% of women who attended subsequent screens were recalled.  
Women screened in 2011 
For women aged 50–69, 10.7% of women screened for the first time were recalled to 
assessment, while 3.8%of women who attended subsequent screens were recalled.  
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More information on recall to assessment 
A woman is recalled to assessment for mammographic reasons because her screening 
mammography images are found to be suspicious for breast cancer. 
Assessment of women recalled involves further investigation by a multidisciplinary team at 
an assessment centre. This may include clinical examination, additional mammography, 
ultrasound and, if required, a biopsy. Most women recalled to assessment are found not to 
have breast cancer (BreastScreen SA 2010). 
Detailed analyses 
Recall to assessment after a screen in 2010 and 2011 
In 2010, of the 79,971 women aged 50–69 attending their first screen, 9,110 (11.4%) were 
recalled to assessment. This equates to 11.1% when age-standardised. In 2011, of the 75,999 
women aged 50–69 attending their first screen, 8,420 (11.1%) were recalled to assessment, 
equating to 10.7% when age-standardised. The NAS for recall to assessment for women who 
attend for their first screen were not met at the national level for 2010 or 2011 (NAS 2.6.1 
being that less than 10% of women aged 50–69 who attend for their first screen are recalled for 
assessment). 
Of the 627,902 women aged 50–69 attending a subsequent screen in 2010, 25,880 (4.1%) were 
recalled to assessment. This equates to 4.2% when age-standardised. Of the 644,766 women 
aged 50–69 attending a subsequent screen in 2011, 24,022 (3.7%) were recalled to assessment, 
equating to 3.8% when age-standardised. These rates are well within the NAS for women 
attending a subsequent screen (NAS 2.6.2 being that less than 5% of women aged 50–69 who 
attend for their second or subsequent screen are recalled for assessment). 
Recall to assessment trends 
Recall to assessment rates for women screened for the first time increased, while this 
remained constant for women attending a subsequent screening round (Table 3.1;  
Figure 3.1).  
For women aged 50–69 attending for the first time, recall to assessment increased to around 
11% of women screened in 2009, 2010 and 2011 (Table 3.1).  
Recall to assessment for women aged 50–69 attending subsequent screening rounds, 
remained at about 4% of women screened for all years to 2011 (Table 3.1).  
Table 3.1: Recall to assessment rate for women aged 50–69, mammographic reasons, first and 
subsequent screening rounds, 2000 to 2011 
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
First screening round           
AS rate 8.2 8.5 8.8 9.4 9.8 9.8 9.9 9.9 9.9 10.7 11.1 10.7 
Subsequent screening rounds          
AS rate 4.1 3.9 4.1 4.0 4.0 3.9 4.0 4.0 4.1 4.2 4.2 3.8 
Note: Rates are the number of women recalled for assessment as a percentage of women screened and age-standardised to the  
population of women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
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Source: AIHW analysis of BreastScreen Australia data. 
Figure 3.1: Recall to assessment rate for women aged 50–69, mammographic reasons, first and 
subsequent screening rounds, 1996 to 2011 
Recall to assessment by age  
 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 3.2: Recall to assessment rate, by age, first and subsequent screening rounds, 2011 
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In 2010, recall to assessment rates for the first screening round were highest for women aged 
45–49 at 12.0% and lowest for women aged 40–44 at 10.5%. In subsequent screening rounds, 
recall to assessment rates were highest for women aged 45–49 at 5.9% and lowest for women 
aged 55–59 and 60-64 at 3.9% (Figure 3.2). 
In 2011, recall to assessment rates for the first screening round were highest for women aged 
50–54 at 11.4% and lowest for women aged 70 or over at 9.1%. In subsequent screening 
rounds, recall to assessment rates were highest for women aged 45–49 at 5.2% and lowest for 
women aged 55–59 at 3.5% (Figure 3.2). 
Recall to assessment by state and territory 
In 2010 and 2011, recall to assessment for women aged 50–69 varied considerably across 
states and territories (only 2011 data are shown in Figure 3.3).  
 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 3.3: Recall to assessment rate for women aged 50–69, by state and territory, first 
and subsequent screening rounds, 2011 
In 2010, recall to assessment rates for women aged 50–69 by state and territory, attending 
their first screen, ranged between 6.9% and 14.9%. The corresponding rates for women aged 
50–69 attending subsequent screens ranged between 1.9% and 5.1% (Table 3.2). 
In 2011, recall to assessment rates for women aged 50–69 attending their first screen ranged 
between 6.2% and 14.3%. The corresponding rates for women aged 50–69 attending 
subsequent screens ranged between 1.8% and 4.4% (Table 3.2). 
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Table 3.2: Recall to assessment rate for women aged 50–69, by state and territory, first and 
subsequent screening rounds, 2010 and 2011  
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2010 
First screening round 
 Number 2,716 3,053 1,850 834 297 148 107 105 9,110 
 AS rate 9.7 12.9 14.9 9.1 6.9 9.3 9.4 11.1 11.1 
Subsequent screening rounds 
 Number 8,538 6,670 6,856 1,821 985 601 283 126 25,880 
 AS rate 4.4 4.6 5.1 2.7 1.9 3.4 3.2 3.8 4.2 
 2011 
First screening round 
Number 2,644 2,764 1,556 769 294 168 140 85 8,420 
AS rate 10.0 12.3 14.3 8.9 6.2 9.7 11.7 8.3 10.7 
Subsequent screening rounds 
Number 8,545 6,068 5,827 1,531 1,037 518 391 105 24,022 
AS rate 4.4 4.1 4.2 2.2 1.8 2.9 4.0 2.9 3.8 
Note: Rates are the number of women recalled for assessment as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data.  
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Indicator 4 Invasive breast cancer detection  
What you need to know about invasive breast cancer detection 
Definition: The number of women with invasive breast cancer detected through 
BreastScreen Australia per 10,000 women screened. The rate is reported for breast cancers of 
all sizes, as well as for a subset of breast cancers that are small (having a diameter less than 
or equal to 15 mm). 
Rationale: The overarching aim of BreastScreen Australia is to reduce morbidity and 
mortality from breast cancer. This can be achieved by detecting cases of unsuspected breast 
cancer before women have symptoms, enabling early intervention. BreastScreen Australia 
strives to maximise the detection of invasive breast cancers, particularly small cancers, to 
achieve the desired reductions in morbidity and mortality. 
The NAS outline that at least 50 per 10,000 women screened aged 50–69 who attend for their 
first screen are diagnosed with invasive breast cancer (NAS 2.1.1), at least 35 women per 
10,000 women screened aged 50–69 who attend for subsequent screens are diagnosed with 
invasive breast cancer (NAS 2.1.2), and that at least 25 women per 10,000 women screened 
aged 50–69 who attend for screening are diagnosed with small (≤15 mm) invasive breast 
cancer (NAS 2.2.1) (BreastScreen Australia 2004). 
Guide to interpretation: Detection of invasive breast cancers is disaggregated into first and 
subsequent screening rounds because a woman is more likely to have a breast cancer 
detected the first time she visits a BreastScreen service than in subsequent visits. This is 
because a woman’s first visit detects prevalent cancers that may have been present for some 
time rather than incident cancers that have grown between screens (Kavanagh et al. 1999). 
Detection of small invasive cancers is presented for all screening rounds combined. 
The most recent cancer detection data are for women screened in 2010 and 2011. 
What the data tell us about invasive breast cancer detection 
  Trend 
Invasive breast cancer detection in the first screening round increased to a peak of 91.6 per 
10,000 women screened in 2010 before decreasing slightly to 82.1 in 2011.  
Detection in subsequent rounds remained steady at around 43–44 per 10,000 women 
screened for most years.  
 
2010  
In 2010, 91.6 per 10,000 women aged 50–69 screened were diagnosed with invasive breast 
cancer in the first screening round, and 44.4 in subsequent screening rounds. 
For women aged 50–69, 60.2% of all invasive breast cancers detected were small (≤15 mm).  
2011  
In 2011, 82.1 women aged 50–69 were diagnosed with invasive breast cancer per 10,000 
women screened in the first screening round, and 42.9 in subsequent screening rounds. 
For women aged 50–69, 61.1% of all invasive breast cancers detected were small (≤15 mm).  
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Detailed analyses  
Invasive breast cancer detection after a screen in 2010 and 2011 
In 2010, 4,472 women were diagnosed with invasive breast cancer, of whom 3,460 (77.4%) 
were aged 50–69, 375 (8.4%) were aged 40–49, and 637 (14.2%) were aged 70 or over.  
Of the 3,460 women aged 50–69 diagnosed with invasive breast cancer in 2010, 581 were 
attending their first screen (equivalent to 72.7 women diagnosed per 10,000 women 
screened) and 2,879 were attending a subsequent screen (equivalent to 45.9 per 10,000). 
When age-standardised to allow analyses of trends, these rates are 91.6 per 10,000 in the first 
screening round and 44.4 per 10,000 in subsequent rounds (Table 4.1). 
In 2011, 4,391 women were diagnosed with invasive breast cancer of whom 3,399 (77.4%) 
were aged 50–69, 336 (7.7%) were aged 40–49 and 656 (14.9%) were aged 70 or over.  
Of the 3,399 women aged 50–69 diagnosed with invasive breast cancer in 2011, 537 were 
attending their first screen (equivalent to 70.7 women diagnosed per 10,000 women 
screened) and 2,862 were attending a subsequent screen (equivalent to 44.4 women per 
10,000). When age-standardised to allow analyses of trends, these rates are 82.1 per 10,000 
women screened in the first screening round and 42.9 per 10,000 women screened in 
subsequent rounds (Table 4.1). 
Table 4.1: All-size and small invasive breast cancer detection in women aged 50–69, first and 
subsequent screening rounds for all-size cancers, and all screening rounds for small cancers, 2010 
and 2011 
 Number AS rate 95% CI 
2010 
 All size     
 First screening round 581 91.6  82.6–101.2 
 Subsequent screening rounds 2,879 44.4  42.8–46.1 
 Small size     
 All screening rounds  2,082 29.2  27.9–30.4 
2011 
 All size     
 First screening round 537 82.1  73.5–91.3 
 Subsequent screening rounds 2,862 42.9  41.3–44.5 
 Small size     
 All screening rounds  2,077 28.4  27.2–29.7 
Notes 
1. The 2010 data may differ from that published in the BreastScreen Australia monitoring report 2009–2010 due to updates to the database.  
2. Rates are the number of women with invasive breast cancer detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
In 2010, of the 3,460 women aged 50–69 diagnosed with invasive breast cancer, 2,082 had a 
small (≤15 mm) cancer diagnosed (29.4 per 10,000 women screened). This is 60.2% of all 
cancers diagnosed in women aged 50–69. Age-standardised, this is 29.2 per 10,000 women 
screened. 
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In 2011, of the 3,399 women aged 50–69 diagnosed with invasive breast cancer, 2,077 had a 
small (≤15 mm) cancer diagnosed (28.8 per 10,000 women screened), equating to 61.1% of all 
cancers diagnosed in women aged 50–69. Age-standardised, this is 28.4 per 10,000 women 
screened. 
These met the NAS for the detection of invasive breast cancer (NAS 2.1.1 being that at least 
50 women per 10,000 women screened aged 50–69 who attend for their first screen are diagnosed with 
invasive breast cancer, and NAS 2.1.2 being that at least 35 women per 10,000 women screened aged 
50–69 who attend for their second or subsequent screen are diagnosed with invasive breast cancer), as 
well as the NAS for the detection of small invasive breast cancer (NAS 2.2.1) being that at 
least 25 women per 10,000 women screened aged 50–69 who attend for screening are diagnosed with 
small (≤15 mm) invasive breast cancer). 
Invasive breast cancer detection trends 
Detection of invasive breast cancers through BreastScreen Australia has increased over time 
(Figure 4.1).  
A  
 
B 
 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 4.1: All-size (A) and small (15 mm), (B) invasive breast cancer detection in women aged  
50–69, first and subsequent screening rounds for all-size cancers, and all screening rounds for 
small cancers, 1996 to 2011 
Detection of invasive breast cancer in the first screening round increased from 69.0 women 
diagnosed per 10,000 women screened in 2000 to 91.6 in 2010; it then decreased slightly to 
82.1 per 10,000 women screened (Figure 4.1A and Table 4.2).  
Detection of invasive breast cancer in subsequent screening rounds increased from 43.1 per 
10,000 women screened in 2000 to 44.4 in 2010; it then decreased slightly to 42.9 per 10,000 
women screened (Figure 4.1A and Table 4.2). 
Detection of small cancers for all screening rounds combined was 28 to 30 per 10,000 women 
screened for most years between 2000 and 2011 (Figure 4.1B and Table 4.3). 
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Table 4.2: All-size invasive breast cancer detection in women aged 50–69, first and subsequent 
screening rounds, 2000 to 2011 
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
First screening round 
AS rate 69.0 69.8 76.0 74.2 82.2 76.6 71.8 77.6 75.5 79.5 91.6 82.1 
95% CI 62.2– 
76.2 
63.1–
76.9 
68.3–
84.2 
66.0–
82.9 
73.3–
91.8 
68.4–
85.4 
63.8–
80.4 
69.8–
86.0 
68.5–
82.9 
71.7–
87.7 
82.6–
101.2 
73.5–
91.3 
Subsequent screening rounds 
AS rate 43.1 43.0 44.2 44.2 43.3 42.1 44.0 42.3 47.8 45.4 44.4 42.9 
95% CI 41.2– 
45.1 
41.2–
44.9 
42.4–
46.1 
42.4–
46.1 
41.5–
45.1 
40.5–
43.9 
42.3–
45.7 
40.7–
44.0 
46.0–
49.6 
43.8–
47.1 
42.8–
46.1 
41.3–
44.5 
Note: Rates are the number of women with invasive breast cancer detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
Table 4.3: Small (15 mm) invasive breast cancer detection rates in women aged 50–69, all screening 
rounds, 2000 to 2011 
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
All screening rounds 
AS rate 30.5 29.8 30.3 29.4 29.6 28.7 29.2 28.0 31.4 30.5 29.2 28.4 
95% CI 29.0–
32.0 
28.4–
31.3 
28.9–
31.8 
28.0–
30.9 
28.3–
31.0 
27.4–
30.1 
27.9–
30.5 
26.7–
29.3 
30.1–
32.8 
29.2–
31.8 
27.9–
30.4 
27.2–
29.7 
Note: Rates are the number of women with small invasive breast cancer detected per 10,000 women screened and age-standardised to the 
population of women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
Proportion of invasive breast cancers detected that are small  
A woman is more likely to be diagnosed with a small cancer in subsequent screening visits 
than her first visit, since her first screening mammogram detects prevalent cancers that may 
have been present for some time, whereas subsequent screens detect incident cancers that 
have grown between screens (Kavanagh et al. 1999). Because they have had less time to 
grow, incident cancers are more likely to be small. 
Box 4.1: Terminology 
Prevalent cancers: the number of cases of invasive breast cancer that are present in the 
population at a given time.  
Incident cancers: the number of new cancers diagnosed in a given time period, in this case 
1 year. 
Accordingly, the proportion of small cancers detected was lower in the first screening round 
(48.2% in 2010 and 49.5% in 2011) than in subsequent screening rounds (62.6% in 2010 and 
63.4% in 2011). 
The proportion of small invasive breast cancers in 2010 was lower in younger age groups: 
51.2% of cancers for women aged 40–49 compared with 60.2% for women aged 50–69 and 
59.7% for women aged 70 and over (BreastScreen Australia monitoring report 2010–2011: 
supplementary data tables, Table S4.7). This trend was also seen in 2011 with 50.9% for women 
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aged 40–49, 61.1% for women aged 50–69 and 65.1% for women aged 70 and over 
(BreastScreen Australia monitoring report 2010–2011: supplementary data tables, Table S4.7). The 
lower proportion of small invasive cancers in young age groups may be related to greater 
breast density in younger women, which makes small invasive breast cancers more difficult 
to visualise using screening mammography (Irwig et al. 1997). More than half of all invasive 
breast cancers detected through BreastScreen Australia in women aged 50–69 were small 
(15 mm), with rates above 60% for all years between 2000 and 2011 (Table 4.4; Figure 4.2). 
Table 4.4: Proportion of small (15 mm) invasive breast cancers detected in women aged 50–69,  
all screening rounds, 2000 to 2011 
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Per cent 65.6 64.5 63.8 62.2 63.5 63.1 62.6 61.4 61.5 62.6 60.2 61.1 
Note: Rates are the number of women with small invasive breast cancer detected as a proportion of the number of women with invasive breast 
cancer detected. 
Source: AIHW analysis of BreastScreen Australia data. 
 
 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 4.2: Number of invasive breast cancers, showing the proportion of small size (15 mm) 
to other size (>15 mm), detected in women aged 50–69, all screening rounds, 1996 to 2011 
Invasive breast cancer detection by age 
Detection of invasive breast cancer increased with age (Figure 4.3), reflecting the increase in 
incidence that occurs with age, as described in Indicator 7a. In 2010, invasive breast cancer 
detection increased from 24.1 per 10,000 women screened for women aged 40–44 to 91.5 for 
women aged 70 or over. In 2011, invasive breast cancer detection increased from 21.8 to 92.3 
for women over the same age (Table 4.5). 
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Source: AIHW analysis of BreastScreen Australia data. 
Figure 4.3: All-size and small (15 mm) invasive breast cancer detection, by age, all screening 
rounds, 2011 
Small invasive breast cancer detection increased with age in 2010 and 2011—from 11.0 per 
10,000 women aged 40–44 to 54.6 per 10,000 women aged 70 or more in 2010, and from 9.4 
per 10,000 women aged 40–44 to 60.1 per 10,000 women aged 70 or more in 2011 (Table 4.5). 
Table 4.5: All-size and small (≤15 mm) invasive breast cancer detection rates, by age, all screening 
rounds, 2010 and 2011 
 Age group (years) 
 40–44 45–49 50–54 55–59 60–64 65–69 70+ 
 2010 
All-size        
 Number 94 281 720 811 1,017 912 637 
 Rate 24.1 38.7 37.7 42.3 54.4 66.0 91.5 
Small        
Number 43 149 383 486 632 581 380 
Rate 11.0 20.5 20.0 25.4 33.8 42.1 54.6 
 2011 
All-size        
 Number 88 248 742 737 1,026 894 656 
 Rate 21.8 33.6 38.9 38.2 53.6 61.4 92.3 
Small        
 Number 38 133 408 449 636 584 427 
 Rate 9.4 18.0 21.4 23.3 33.2 40.1 60.1 
Note: Rates are age-specific rates. 
Source: AIHW analysis of BreastScreen Australia data. 
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Invasive breast cancer detection by state and territory 
The number of women with invasive breast cancer diagnosed per 10,000 women screened 
showed considerable variation among states and territories. These data should be interpreted 
with caution because, due to small numbers, none of the observed differences were 
statistically significant (Figure 4.4; Table 4.6). 
Table 4.6: All-size and small (15 mm) invasive breast cancer detection rates in women aged 50–69, 
by state and territory, 2010 and 2011 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2010 
All-size, first screening round 
 Number 198 150 100 68 28 22 8 7 581 
 AS rate 84.3 103.4 91.4 91.5 96.3 149.6 151.9 83.8 91.6 
 95% CI 71.7–98.2 79.2–130.6 71.9–114.0 62.9–125.8 47.5–161.1 84.7–239.1 19.1–378.7 26.5–185.4 82.6–101.2 
All size, subsequent screening rounds       
 Number 842 678 654 309 249 81 46 20 2,879 
 AS rate 41.8 44.2 47.7 43.6 46.3 43.9 49.0 58.2 44.4 
 95% CI 39.0–44.7 40.9–47.8 44.1–51.5 38.8–48.7 40.7–52.5 34.8–54.7 35.7–65.5 35.3–90.4 42.8–46.1 
Small, all screening rounds        
 Number 615 481 477 211 187 59 37 15 2,082 
 AS rate 27.3 28.1 32.3 27.2 32.3 29.4 36.6 36.7 29.2 
 95% CI 25.2–29.6 25.6–30.7 29.5–35.3 23.7–31.2 27.9–37.3 22.4–37.9 25.8–50.5 20.3–61.0 27.9–30.4 
 2011 
All-size, first screening round 
Number 148 156 110 61 24 18 13 7 537 
AS rate 64.0 100.0 110.9 83.8 62.6 110.9 112.4 115.2 82.1 
95% CI 53.0–76.4 76.0–127.0 88.0–137.2 53.0–121.1 28.1–109.5 62.2–180.3 44.5–215.5 16.5–290.2 73.5–91.3 
All size, subsequent screening rounds 
Number 815 697 646 310 240 81 58 15 2,862 
AS rate 40.4 43.8 45.7 43.7 39.4 43.7 52.8 41.8 42.9 
95% CI 37.6–43.3 40.5–47.2 42.3–49.4 39.0–48.9 34.5–44.7 34.6–54.4 39.8–68.6 23.3–69.2 41.3–44.5 
Small, all screening rounds 
Number 598 501 457 234 161 69 41 16 2,077 
AS rate 26.7 28.4 30.4 30.1 24.8 34.5 34.9 38.8 28.4 
95% CI 24.6–28.9 25.9–31.0 27.6–33.3 26.4–34.2 21.1–28.9 26.8–43.6 25.0–47.4 21.9–63.3 27.2–29.7 
Notes  
1. Rates are the number of women with invasive breast cancer detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 2008; rates based on numbers less than 20 should be interpreted with caution. 
2. State and territory differences, along with the size of the 95% confidence intervals (particularly in the smaller states and territories), need to 
be taken into consideration when interpreting cancer detection results.  
3. In some states and territories, age-standardised rates vary considerably from crude rates. Crude rates are available in the BreastScreen 
Australia monitoring report 2010–2011: supplementary data tables. 
Source: AIHW analysis of BreastScreen Australia data. 
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Notes 
1. Rates are the number of women with invasive breast cancer detected per 10,000 women screened and age-standardised to 
the population of women attending a BreastScreen Australia service in 2008; rates based on numbers less than 20 should be 
interpreted with caution. 
2. Bars on columns represent 95% confidence intervals. 
Source: AIHW analysis of BreastScreen Australia data.  
Figure 4.4: All-size invasive breast cancer detection in women aged 50–69, by state and 
territory, first and subsequent screening rounds, 2011 
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Indicator 5 Ductal carcinoma in situ detection 
What you need to know about DCIS detection 
Definition: The number of women with ductal carcinoma in situ (DCIS) detected through 
BreastScreen Australia per 10,000 women screened. 
Rationale: Women with DCIS are at an increased risk of later developing invasive breast 
cancer (AIHW 2010a; WHO & IARC 2002). Research has shown that invasive breast cancer 
may also occur after treated cases of DCIS, either in the opposite breast or independently of 
the original DCIS in the same breast (Kerlikowske et al. 2010).  
It is not currently possible to predict which DCIS cases might progress to invasive breast 
cancer. However, given the increased risk of invasive breast cancer after a diagnosis of DCIS, 
and that the detection and subsequent treatment of high-grade DCIS is likely to prevent 
deaths from invasive breast cancer (Eusebi et al. 1994), BreastScreen Australia aims to 
maximise the detection of DCIS. This is reflected in the NAS for detection of DCIS that 
requires that, for women aged 50–69, at least 12 women per 10,000 women screened who 
attend their first screen are diagnosed with DCIS (NAS 2.3.1), and that at least 7 women per 
10,000 women screened who attend for subsequent screens are diagnosed with DCIS 
(NAS 2.3.2) (BreastScreen Australia 2004).  
Guide to interpretation: DCIS is disaggregated into first and subsequent screening rounds 
because a woman is more likely to have DCIS diagnosed at her first screen than subsequent 
screens, since her first visit detects prevalent cases, not just incident cases.  
To produce stable, comparable rates from the relatively small number of DCIS cases, 
detection of DCIS is reported by 10-year age groups and, when disaggregated by state and 
territory, is presented for all screening rounds combined.  
The most recent DCIS detection data are for women screened in 2010 and 2011. 
What the data tell us about DCIS detection 
 Trend 
DCIS detection has remained relatively stable over the last 10 years. 
 
2010 
For women aged 50–69, 17.9 per 10,000 women screened were diagnosed with DCIS in the 
first screening round, and 11.5 per 10,000 in subsequent rounds. 
2011 
For women aged 50–69, 20.9 per 10,000 women screened were diagnosed with DCIS in the 
first screening round, and 11.2 per 10,000 in subsequent rounds. 
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More information on DCIS 
DCIS is a non-invasive tumour that arises from the lining of the ducts that carry milk from 
the milk-producing lobules to the nipple. The changes to the cells lining the milk ducts seen 
in DCIS are similar to those in invasive breast cancer. However, unlike breast cancer, DCIS 
does not invade the surrounding breast tissue and is, instead, contained entirely within the 
milk duct. 
Most cases of DCIS are asymptomatic. They are usually detected as a change on a 
mammogram or as a chance finding on a breast biopsy for another condition (BreastScreen 
Australia 2004). DCIS was rarely discovered before the introduction of screening 
mammography. The introduction and progressive expansion of national organised screening 
mammography from 1991 (in the form of BreastScreen Australia) resulted in a substantial 
increase in its detection (Luke et al. 2006; NBBC et al. 2000).  
Women with DCIS are at an increased risk of later developing invasive breast cancer 
(AIHW 2010a; WHO & IARC 2002). Research has shown that invasive breast cancer may also 
occur after treated cases of DCIS, either in the opposite breast or independently of the 
original DCIS in the same breast (Kerlikowske et al. 2010). BreastScreen Australia therefore 
aims to maximise the detection of DCIS in Australian women. 
Detailed analyses 
DCIS detection after a screen in 2010 and 2011 
In 2010, 1,103 women were diagnosed with DCIS by BreastScreen Australia, of whom 876 
(79.4%) were aged 50–69. Of these 876 women, 142 were attending their first screen 
(equivalent to 17.9 women diagnosed per 10,000 women screened) and 734 were attending a 
subsequent screen (equivalent to 11.5 per 10,000 women screened) (Table 5.1). 
In 2011, the data show a similar trend with 1,120 women diagnosed with DCIS, of whom 881 
(78.7%) were aged 50–69. Of these 881 women, 141 were attending their first screen 
(equivalent to 20.9 women diagnosed per 10,000 women screened) and 740 were attending a 
subsequent screen (equivalent to 11.2 per 10,000 women screened) (Table 5.1). 
Table 5.1: DCIS detection in women aged 50–69, first and subsequent screening rounds,  
2010 and 2011  
 Number AS rate 95% CI 
2010  
 First screening round 142 17.9 14.1–22.1 
 Subsequent screening rounds 734 11.5 10.7–12.4 
2011  
 First screening round 141 20.9 16.7–25.7 
 Subsequent screening rounds 740 11.2 10.4–12.1 
Note: Rates are the number of women with DCIS detected per 10,000 women screened and age-standardised to the population of women 
attending a BreastScreen Australia service in 2008.  
Source: AIHW analysis of BreastScreen Australia data. 
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These met the NAS for the detection of DCIS (NAS 2.3.1 being that at least 12 women per 
10,000 women screened aged 50–69 who attend their first screen are diagnosed with DCIS, and NAS 
2.3.2 being that at least 7 women per 10,000 women screened aged 50–69 who attend for subsequent 
screens are diagnosed with DCIS). 
DCIS detection trends 
Detection of DCIS in women aged 50–69 in the first screening round varied between 15 and 
21 per 10,000 women screened over the years 2000 to 2011, with these rates having relatively 
broad confidence intervals (Figure 5.1; Table 5.2). 
Detection of DCIS in women aged 50–69 in subsequent screening rounds increased from 
about 10.4 in 2000 to range between 11 and 12 per 10,000 women screened for all years from 
2007 to 2011 (Figure 5.1; Table 5.2). 
 
Note: Rates are the number of women with DCIS detected per 10,000 women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 2008; rates based on numbers less than 20 should be interpreted with caution. 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 5.1: DCIS detection in women aged 50–69, by year, 1996 to 2011  
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Table 5.2: DCIS detection in women aged 50–69, first and subsequent screening rounds, 2000 to 
2011 
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
First screening round 
AS rate 14.9 19.5 21.4 16.7 20.4 14.5 18.8 21.3 15.6 19.6 17.9 20.9 
95% CI 11.9– 
18.4 
16.1– 
23.3 
17.6– 
25.8 
13.0– 
21.0 
16.1– 
25.4 
11.2– 
18.4 
14.9– 
23.3 
17.3– 
25.7 
12.7– 
18.8 
16.0– 
23.6 
14.1–
22.1 
16.7–
25.7 
Subsequent screening rounds 
AS rate 10.4 10.2 9.3 10.3 10.7 11.0 9.7 11.1 11.5 11.7 11.5 11.2 
95% CI 9.5– 
11.4 
9.3– 
11.1 
8.5– 
10.2 
9.4– 
11.2 
9.8– 
11.6 
10.2– 
11.9 
8.9– 
10.6 
10.3– 
12.0 
10.7– 
12.4 
10.9– 
12.6 
10.7–
12.4 
10.4–
12.1 
Note: Rates are the number of women with DCIS detected per 10,000 women screened and age-standardised to the population of women 
attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
 
Detection of DCIS by age 
Similar to invasive breast cancer detection, DCIS detection increases with age. 
In 2010, the rate of women diagnosed with DCIS per 10,000 women screened increased from 
10.5 for women aged 40–49 to 11.6 for women aged 50–59, 13.3 for women aged 60–69 and 
15.8 for women aged 70 and over (Table 5.3). 
In 2011, the rate of women diagnosed with DCIS per 10,000 women decreased slightly from 
11.1 for women aged 40–49 to 10.8 for women aged 50–59, then increased to 13.8 for women 
aged 60–69 and to 15.8 for women aged 70 and over (Table 5.3). 
Table 5.3: Age-specific detection rates for DCIS, all screening rounds, by age, 2010 and 2011 
 Age group (years) 
 40–49 50–59 60–69 70+ 
2010  
 Number 117 442 434 110 
 Age-specific rate 10.5 11.6 13.3 15.8 
2011  
 Number 127 415 466 112 
 Age-specific rate 11.1 10.8 13.8 15.8 
Note: Rates are the number of women with DCIS detected per 10,000 women screened. 
Source: AIHW analysis of BreastScreen Australia data. 
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Detection of DCIS by state and territory 
DCIS detection across states and territories for all screening rounds combined in 2010 and 
2011 is shown in Table 5.4. Figure 5.2 show data for 2011 only.  
 
Note: Rates are the number of women with DCIS detected per 10,000 women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 2008; rates based on numbers less than 20 should be interpreted with caution. 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 5.2: DCIS detection in women aged 50–69, by state and territory, all screening 
rounds, 2011  
Table 5.4: DCIS detection in women aged 50–69, by state and territory, all screening rounds, 
 2010 and 2011  
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2010 
Number 255 197 228 96 57 23 13 7 876 
AS rate 11.5 11.5 15.4 12.4 10.0 11.1 13.1 18.9 12.3 
95% CI 10.1–13.0 10.0–13.3 13.5–17.6 10.1–15.2 7.6–12.9 7.0–16.7 7.0–22.5 7.4–39.4 11.5–13.2 
 2011 
Number 230 220 185 131 62 30 17 6 881 
AS rate 10.3 12.6 12.3 16.9 9.7 14.8 14.9 13.5 12.1 
95% CI 9.0–11.8 11.0–14.4 10.6–14.2 14.1–20.0 7.4–12.4 10.0–21.2 8.6–23.9 4.8–29.5 11.4–13.0 
Notes 
1. Rates are the number of women with DCIS detected per 10,000 women screened and age-standardised to the population of women 
attending a BreastScreen Australia service in 2008; rates based on numbers less than 20 should be interpreted with caution.  
2. State and territory differences, along with the size of the 95% confidence intervals (particularly in the smaller states and territories), need to 
be taken into consideration when interpreting DCIS detection results.  
3. In some states and territories, the age-standardised rates vary considerably from the crude rates. Crude rates are available in the 
BreastScreen Australia monitoring report 2010–2011: supplementary data tables. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 6a Interval cancers 
What you need to know about interval cancers 
Definition: The number of invasive breast cancers detected in women screened through 
BreastScreen Australia that arise during an interval between two screening rounds, per 
10,000 women-years. 
Rationale: The ability of screening mammography to successfully detect invasive breast 
cancer in women in the target age group can be assessed by considering the relative number 
of: 
• invasive breast cancers detected at screening episode 
• invasive breast cancers diagnosed 0–12 months after a screening episode detected no 
cancer 
• invasive breast cancers diagnosed 13–24 months after a screening episode detected no 
cancer. 
The goal of BreastScreen Australia is to have a high proportion of invasive breast cancers 
detected within screening episodes and a low proportion diagnosed after a screening 
episode detected no cancer (interval cancers).  
This is reflected in NAS for interval breast cancers that require that less than 7.5 interval 
cancers per 10,000 women aged 50–69 are diagnosed in women who attend for screening less 
than 12 months after a negative screening episode (NAS 2.4.2(a)) (BreastScreen Australia 
2004). 
Guide to interpretation: Interval cancer rates are disaggregated into time since screening  
(0–12 months, 13–24 months and 0–24 months) and screening round (first and subsequent).  
To produce comparable rates from the relatively small number of cases, interval cancer rates 
are reported by 10-year age groups, and aggregated over 3 years. 
The most recent interval cancer data are for women screened in the index years 2005–2007 
and 2006–2008. This small lag in data availability is because 2 years need to have passed 
since a woman’s last screen to know whether she was diagnosed with an interval cancer. 
What the data tell us about interval cancers 
Interval cancers for the index years 2006, 2007 and 2008 
In the 0–12 months after a woman’s first negative screening episode, there were 5.5 interval 
cancers per 10,000 women-years. In the 0–12 months after subsequent negative screening 
episodes, there were 6.6 interval cancers per 10,000 women-years. 
In the 13–24 months after a woman’s first negative screening episode, there were 
12.6 interval cancers per 10,000 women-years. In the 13–24 months after subsequent 
negative screening episodes, there were 11.8 interval cancers per 10,000 women-years. 
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More information on interval cancers 
Invasive breast cancers that are diagnosed after a screening episode that detected no cancer 
and before the next scheduled screening episode are known as ‘interval’ cancers (Kavanagh 
et al. 1999). An interval cancer may be:  
• an aggressive breast cancer that emerges and grows very rapidly in the period between 
scheduled screening episodes  
• a breast cancer that, due to the characteristics of the cancer or the breast tissue, is not 
visible on screening mammography and therefore not able to be detected 
• a breast cancer that can be retrospectively detected on the previous screening 
mammogram (BreastScreen SA 2010).  
The first two types of interval cancer described above are true interval cancers, and therefore 
do not represent any failure in detection; the third represents a failure of the screening 
process. Through the BreastScreen accreditation process, state and territory BreastScreen 
programs are required to audit interval cancers. On investigation, more than 80% are found 
to be true interval cancers.  
State and territory BreastScreen programs source information about breast cancers 
diagnosed outside the program from jurisdictional cancer registries to help to identify 
interval cancers (Kavanagh et al. 1999).  
Detailed analyses 
Interval cancers for the index years 2005–2007 and 2006–2008 
For the index years 2005–2007 combined, in the 0–12 months after a woman’s first negative 
screening episode, there were 5.4 interval cancers per 10,000 women-years; in the 0–12 
months after subsequent negative screening episodes, there were 6.7 interval cancers per 
10,000 women-years (Table 6.1). 
The interval cancer rate was higher in the 13–24 months after a negative screening episode 
than in the 0–12 months after a negative screening episode. 
In the 13–24 months after a woman’s first negative screening episode, there were 
14.0 interval cancers per 10,000 women-years; in the 13–24 months after subsequent negative 
screening episodes, there were 11.8 interval cancers per 10,000 women-years (Table 6.2). 
For the index years 2006–2008 combined, in the 0–12 months after a woman’s first negative 
screening episode, there were 5.5 interval cancers per 10,000 women-years; in the 0–12 
months after subsequent negative screening episodes, there were 6.6 interval cancers per 
10,000 women-years (Table 6.1).  
Similar to the previous trend, the interval cancer rate in 2006–2008 was higher in the 13–24 
months after a negative screening episode than in the 0–12 months after a negative screening 
episode.  
In the 13–24 months after a woman’s first negative screening episode, there were 
12.6 interval cancers per 10,000 women-years; in the 13–24 months after subsequent negative 
screening episodes, there were 11.8 interval cancers per 10,000 women-years (Table 6.2). 
For both 2005–2007 and 2006–2008, the observed rates were well within the NAS (NAS 
2.4.2(a) being that less than 7.5 interval cancers per 10,000 women aged 50–69 are diagnosed in 
women who attend for screening less than 12 months after a negative screening episode). 
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Table 6.1: Interval cancer rate for women aged 50–69, screened in index years 2005–2007 and  
2006–2008, by state and territory, first and subsequent screening rounds, 0–12 months follow-up 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2005–2007 
First screening round 
AS rate  5.8 5.9 5.5 1.8 3.5 5.8 3.0 3.5 5.4 
95% CI 4.1–8.0 3.4–8.9 3.3–8.4 0.7–3.9 1.4–7.1 0.1–22.8 0.4–10.8 0.1–19.3 4.3–6.7 
Subsequent screening rounds 
AS rate  7.0 6.8 6.8 5.9 6.3 8.2 5.6 2.6 6.7 
95% CI 6.3–7.7 6.0–7.7 5.9–7.7 4.8–7.2 5.1–7.7 5.7–11.3 3.1–9.2 0.3–9.6 6.3–7.1 
 2006–2008 
First screening round 
AS rate 6.3 5.5 4.5 3.2 4.9 1.6 2.9 6.6 5.5 
95% CI 4.5–8.5 3.6–7.9 2.5–7.5 0.0–10.7 2.5–8.8 0.0–8.9 0.4–10.6 0.8–24.0 4.4–6.8 
Subsequent screening rounds 
AS rate 7.4 6.3 6.5 5.3 6.7 6.6 4.9 3.7 6.6 
95% CI 6.7–8.2 5.5–7.1 5.7–7.4 4.3–6.5 5.5–8.2 4.4–9.4 2.6–8.4 0.7–10.8 6.2–7.0 
Note: Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
Table 6.2: Interval cancer rate for women aged 50–69, screened in index years 2005–2007 and  
2006–2008 by state and territory, first and subsequent screening rounds, 13–24 months follow-up 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2005–2007 
First screening round 
AS rate  14.5 18.6 9.9 20.0 7.2 14.0 4.7 0.0 14.0 
95% CI 11.4–18.0 12.9–25.3 6.8–13.9 11.0–31.8 1.0–17.9 4.5–30.8 1.0–13.8 . . 12.0–16.2 
Subsequent screening rounds 
AS rate  11.6 12.6 12.1 9.4 12.5 11.6 9.4 7.7 11.8 
95% CI 10.7–12.6 11.5–13.7 11.0–13.4 7.9–11.0 10.7–14.5 8.5–15.5 5.9–14.2 2.8–16.8 11.2–12.3 
 2006–2008 
First screening round 
AS rate 14.8 12.9 9.9 11.6 10.1 20.1 3.1 0.0 12.6 
95% CI 11.1–19.1 8.8–17.8 6.6–14.2 5.7–19.6 3.2–20.1 6.9–42.5 0.4–11.3 . . 10.6–14.8 
Subsequent screening rounds 
AS rate 11.3 12.8 12.4 8.6 13.4 11.1 9.8 11.5 11.8 
95% CI 10.2–12.5 11.7–14.0 11.2–13.6 7.2–10.1 11.5–15.4 8.1–14.9 6.1–14.8 5.2–21.9 11.3–12.4 
Notes 
1.  New South Wales data are based on the index years 2005, 2006 and 2007 only.  
2. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
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As can be seen from tables 6.1 and 6.2, for the reporting periods 2005–2007 and 2006–2008, 
there were no appreciable differences in the interval cancer rate between first and 
subsequent screening rounds for either 0–12 months or 13–24 months after a negative 
screening episode. This indicates that, although women are more likely to have an invasive 
breast cancer detected in their first screening round compared with subsequent screening 
rounds, they are no more likely to have an interval cancer diagnosed after their first screen 
than after any other screen at a BreastScreen Australia service. 
Box 6.1: What is a screening episode? 
A screening episode includes all attendances for screening and assessment within 6 months 
relating to a particular round of screening. It starts at the date of attendance for screening. It 
is completed when: 
 a recommendation is made to return the woman to routine rescreening 
 a recommendation is made for early review at 6 months or more from the screening 
date 
 a diagnosis of cancer is made 
 the woman fails to attend for technical recall or assessment within 6 months 
 the woman dies. 
Interval cancer by age 
When looking at the pattern of interval cancers by age, 10-year age groups and data for all 
screening rounds combined are used to produce meaningful rates from the relatively small 
number of cases. The interval cancer rate was lowest for women aged 50–59, followed by that 
for those aged 60–69, and was higher for women outside the target age group (Table 6.3).  
Table 6.3: Interval cancer rate for women screened in index years 2005–2007 and 2006–2008, all 
screening rounds, by age, 0–12 months and 13–24 months follow-up 
Time since screen (months) 
 Age group (years) 
 40–49 50–59 60–69 70+ 
   2005–2007 
0–12 months Number  271 715 540 181 
 Crude rate  7.7 6.5 6.8 8.2 
13–24 months Number  411 1,175 973 276 
 Crude rate  12.3 11.2 12.9 13.2 
   2006–2008 
0–12 months Number  280 714 541 181 
 Crude rate  8.0 6.5 6.6 8.6 
13–24 months Number  395 1,026 935 266 
 Crude rate  12.7 10.8 13.4 14.0 
Notes 
1.  New South Wales data are based on the index years 2005, 2006 and 2007 only.  
2. Rates are the number of interval cancers detected per 10,000 women-years. 
Source: AIHW analysis of BreastScreen Australia data. 
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Interval cancer by state and territory 
Interval cancer rates are shown for states and territories in tables 6.1, 6.2 and 6.4.  
It should be noted that differences in state and territory policies for managing women with 
symptoms may affect interval cancer rates. For example, in some jurisdictions, women are 
not recalled to assessment on the basis of symptom status; those women with a negative 
screen but who have symptoms are referred for diagnostic follow-up outside BreastScreen 
Australia. Those referred women who later have a cancer diagnosis will be counted as 
interval cancers, leading to a higher apparent interval cancer rate. Other states that do recall 
on the basis of symptoms may have lower apparent interval cancer rates. This affects the 
comparability of this indicator between jurisdictions. 
Table 6.4: Interval cancer rate for women aged 50–69, screened in index years 2005–2007 and  
2006–2008, by state and territory, first and subsequent screening rounds, 0–24 months follow-up 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2005–2007 
First screening round        
AS rate  10.0 12.2 7.7 11.7 5.3 9.8 3.8 1.7 9.7 
95% CI 8.2–12.0 9.1–15.8 5.7–10.1 6.5–18.2 1.9–10.3 3.7–20.0 1.2–8.9 0.0–9.7 8.5–10.9 
Subsequent screening rounds 
AS rate  9.2 9.7 9.4 7.5 9.3 9.8 7.3 5.1 9.2 
95% CI 8.6–9.8 9.0–10.4 8.7–10.2 6.6–8.6 8.2–10.5 7.8–12.2 5.2–10.1 2.2–10.2 8.9–9.5 
 2006–2008 
First screening round        
AS rate 9.5 9.2 7.2 7.5 7.4 10.5 3.0 3.3 8.7 
95% CI 7.7–11.6 6.9–11.9 5.2–9.7 3.7–12.6 3.7–12.4 4.0–21.2 0.8–7.7 0.4–12.1 7.7–9.9 
Subsequent screening rounds        
AS rate 8.9 9.5 9.4 6.9 9.9 8.7 7.2 7.6 9.0 
95% CI 8.3–9.6 8.9–10.2 8.7–10.2 6.0–7.8 8.8–11.1 6.8–10.9 5.0–10.0 3.9–13.3 8.7-9.4 
Notes 
1.  New South Wales data are based on the index years 2005, 2006 and 2007 only. 
2. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 6b Program sensitivity 
What you need to know about program sensitivity 
Definition: Program sensitivity is directly related to interval cancers. It is the proportion of 
invasive breast cancers detected by BreastScreen Australia (screen-detected cancers) out of 
all invasive breast cancers (interval cancers plus screen-detected cancers) diagnosed in 
program-screened women in the screening interval. 
Rationale: High program sensitivity indicates that few cancers in screened women are 
missed by BreastScreen Australia—that is, most breast cancers are detected by BreastScreen 
Australia as reported in Indicator 4 rather than as interval cancers. 
While there are no NAS that directly relate to the program sensitivity indicator, high 
sensitivity is desirable. 
Guide to interpretation: Program sensitivity is disaggregated into time since screening  
(0–12 months and 0–24 months) and screening round (first and subsequent). 
To produce comparable rates from the relatively small number of cases, interval cancer rates 
are reported by 10-year age groups, and aggregated over 3 years.  
The most recent program sensitivity data are for women screened in the index years  
2005–2007 and 2006–2008. This small lag in data availability is because 2 years need to have 
passed since a woman’s last screen to know whether she was diagnosed with an interval 
cancer. 
What the data tell us about program sensitivity 
Program sensitivity for the index years 2006, 2007 and 2008  
Program sensitivity for 0–12 months was 92.9% for the first screening round and 86.9% for 
subsequent screening rounds. For the same years, program sensitivity for 0–24 months was 
81.4% for the first screening round and 72.1% for subsequent screening rounds.  
For all screening rounds combined, program sensitivity for 0–12 months increased with age, 
from 78.2% in women aged 40–49 to 85.9% and 90.2% for women aged 50–59 and 60–69, 
respectively, and to 90.4% for women aged 70 or over.  
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Detailed analyses 
Program sensitivity for the index years 2005–2007 and 2006–2008 
For the index years 2005–2007 combined, program sensitivity for 0–12 months was 92.7% for 
the first screening round and 86.1% for subsequent screening rounds (Table 6.5). 
Overall program sensitivity (0–24 months) was 79.8% for the first screening round and 71.0% 
for subsequent screening rounds (Table 6.6). 
For the index years 2006–2008 combined, program sensitivity for 0-12 months was 92.9% for 
the first screening round and 86.9% for subsequent screening rounds (Table 6.5).  
Overall program sensitivity (0–24 months) was 81.4% for the first screening round and 72.1% 
for subsequent screening rounds (Table 6.6). 
Table 6.5: Program sensitivity for women aged 50–69, screened in index years 2005–2007 and  
2006–2008, by state and territory, first and subsequent screening rounds, 0–12 months follow-up 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2005–2007 
First screening round        
AS rate 92.1 91.6 93.0 97.5 93.8 94.3 95.7 93.0 92.7 
95% CI 84.1–
100.0 
79.8–
100.0 
82.0–
100.0 
78.4–
100.0 
70.5–
100.0 
64.9–
100.0 
58.5–
100.0 
50.8–
100.0 
87.6– 
98.1 
Subsequent screening rounds 
AS rates 85.3 85.6 87.0 86.7 88.0 81.3 88.8 94.6 86.1 
95% CI 81.8– 
89.0 
81.4– 
89.9 
82.6– 
91.5 
80.4– 
93.3 
81.3– 
95.1 
69.8– 
94.3 
73.2–
100.0 
65.9–
100.0 
84.1– 
88.1 
 2006–2008 
First screening round 
AS rate 92.4 91.4 94.8 97.3 90.4 97.2 95.7 89.9 92.9 
95% CI 84.8–
100.0 
79.3–
100.0 
83.6–
100.0 
79.9–
100.0 
70.0–
100.0 
66.3–
100.0 
55.8–
100.0 
49.6–
100.0 
88.0– 
98.1 
Subsequent screening rounds 
AS rates  85.3 87.4 87.7 88.3 87.0 83.9 90.5 91.9 86.9 
95% CI 81.9– 
88.9 
83.3– 
91.6 
83.5– 
92.0 
82.0– 
94.9 
80.4– 
94.0 
71.9– 
97.2 
75.2–
100.0 
63.7–
100.0 
84.9– 
88.8 
Note: Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and  
age-standardised to the population of women attending a BreastScreen Australia in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
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No significant difference was found in program sensitivity between the first screening round 
and subsequent screening rounds for 0–12 months. In contrast, program sensitivity was 
significantly lower for subsequent screening rounds than for the first screening round for 
overall program sensitivity (0–24 months) (Table 6.6). 
Table 6.6: Program sensitivity for women aged 50–69, screened in index years 2005–2007 and  
2006–2008 , by state and territory, first and subsequent screening rounds, 0–24 months follow-up 
 NSW Vic Qld WA SA Tas ACT NT Australia 
 2005–2007 
First screening round        
AS rates 78.5 75.0 83.3 81.6 86.4 79.5 93.8 93.0 79.8 
95%CI 71.7–
85.8 
65.2–
85.6 
73.2–
94.2 
66.3–
98.9 
64.7–
100.0 
54.5–
100.0 
56.9–
100.0 
50.8–
100.0 
75.4–
84.4 
Subsequent screening rounds 
AS rates 69.6 67.6 70.7 83.4 71.8 67.0 83.4 81.4 71.0 
95%CI 67.1–
72.9 
64.3–
70.9 
67.2–
74.3 
77.3–
89.9 
66.4– 
77.6 
57.5– 
77.5 
69.0–
100.0 
56.7–
100.0 
69.4–
72.7 
 2006–2008 
First screening round 
AS rates 79.2 78.1 85.5 88.0 80.4 79.1 95.7 89.9 81.4 
95%CI 71.2–
87.9 
67.5–
89.7 
75.4–
96.5 
72.0–
100.0 
61.7–
100.0 
53.8–
100.0 
55.8–
100.0 
49.6–
100.0 
76.7–
86.4 
Subsequent screening rounds 
AS rates  70.1 69.7 71.7 84.8 70.4 69.3 84.3 73.9 72.1 
95% CI 66.6–
73.7 
66.5–
73.0 
68.3–
75.3 
78.8–
91.2 
65.1– 
76.0 
59.6– 
80.2 
70.3–
100.0 
51.2–
100.0 
70.4–
73.8 
Notes 
1. New South Wales data are based on the index years 2005, 2006 and 2007 only. 
2. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and  
age-standardised to the population of women attending a BreastScreen Australia service in 2008. 
Source: AIHW analysis of BreastScreen Australia data. 
Program sensitivity by age 
In both 2005–2007 and 2006–2008, program sensitivity was lowest in women aged 40–49, 
thereafter increasing with age (Table 6.7). 
Lower sensitivity means that BreastScreen Australia is less able to detect invasive breast 
cancers in women aged 40–49 who attend for screening.  
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Table 6.7: Program sensitivity for women screened in index years 2005–2007 and 2006–2008, all 
screening rounds, by age, 0–12 months and 0–24 months follow-up 
Time since screen (months) 
 Age group (years) 
 40–49 50–59 60–69 70+ 
2005–2007   
 0–12    78.3 85.3 89.4 90.3 
 0–24    59.9 69.7 75.7 79.0 
2006–2008   
 0–12   78.2 85.9 90.2 90.4 
 0–24    60.3 70.8 76.5 78.6 
Notes 
1.  New South Wales data are based on the index years 2005, 2006 and 2007 only. 
2. Rates are the number of interval cancers detected per 10,000 women-years. 
Source: AIHW analysis of BreastScreen Australia data. 
Program sensitivity by state and territory 
Program sensitivity is shown for states and territories in tables 6.5 and 6.6. 
As noted for the interval cancer indicator, both interval cancers and sensitivity rates in each 
state and territory are affected by the varying policies for managing symptomatic women. 
This affects the comparability of this indicator between jurisdictions. 
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Indicator 7a Invasive breast cancer incidence 
What you need to know about invasive breast cancer incidence 
Definition: The number of new cases of invasive breast cancer per 100,000 estimated 
resident female population in a 12-month period. 
Rationale: Incidence data provide information about the underlying level of invasive breast 
cancer in Australia. Annual monitoring of these data with various stratifications (such as age 
or location) may reveal findings of concern or positive trends that can be used to inform 
BreastScreen Australia as well as broader policies for breast cancer in Australian women. 
Guide to interpretation: These data include both screen-detected breast cancers (detected 
through BreastScreen Australia) and breast cancers detected outside BreastScreen Australia. 
Incidence data are reported per 100,000 women in the population. 
Incidence of invasive breast cancer by state and territory, remoteness area, socioeconomic 
status and Indigenous status is reported over a 5-year (instead of a 12-month) period. This is 
to improve the stability and comparability of rates due to the small number of new cases in 
less populated areas and in Aboriginal and Torres Strait Islander women. Invasive breast 
cancer incidence data are presented for women aged 50–69 and for all Australian women 
(unlike Indicators 1–6, this includes women aged under 40). 
The Australian Cancer Database is the source of breast cancer incidence data.  
The most recent invasive breast cancer incidence data are for new cases diagnosed in 2009. 
What the data tell us about invasive breast cancer incidence 
 Trend 
The number of new breast cancer cases in women aged 50–69 more than doubled between 
1982 (the first year for which cancer incidence data are available) and 2009 from 2,456 new 
cases to 7,022 new cases. Over this same time, the incidence rate increased from 175.4 to 
288.2 new cases per 100,000 women. The rate has been roughly stable since 2003. 
 
2009 
There were 7,022 new cases of breast cancer in women aged 50–69, the target population of 
BreastScreen Australia, or 288.2 new cases per 100,000 women. There were 13,668 new 
cases, or 113.5 new cases per 100,000 women, in women of all ages. 
New cases diagnosed in women aged 50–69 comprised 51.4% of all invasive breast cancers. 
 
2004–2008 
Invasive breast cancer incidence in Aboriginal and Torres Strait Islander women was 
significantly lower than that for non-Indigenous women, at 213.3 new cases per 
100,000 women aged 50–69 compared with the non-Indigenous rate of 262.9 per 100,000.   
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More information on incidence 
Registration of cancer cases is required by law in each state and territory in Australia. Data 
are collected by state and territory cancer registries and compiled in the national Australian 
Cancer Database, held by the AIHW. The data include clinical and demographic information 
about people with newly diagnosed cancer.  
Invasive breast cancer incidence measures the number of new cases of breast cancer 
diagnosed each year, sourced from the Australian Cancer Database. Only primary breast 
cancers are included—secondary breast cancers and breast cancers that are a reoccurrence of 
a primary breast cancer are not counted. Note that incidence data refer to the number of new 
cases diagnosed and not the number of women diagnosed (although it is rare for a woman to 
be diagnosed with more than one primary breast cancer in the same year).  
The main data source for this chapter was the 2009 Australian Cancer Database. Note that, 
since 2009, incidence data include estimates for New South Wales and the Australian Capital 
Territory data which require disaggregation could only be presented to 2008. 
Detailed analyses 
Invasive breast cancer incidence in 2009  
There were 13,668 new cases of breast cancer in Australian women in 2009. This is equivalent 
to 124.0 new cases for every 100,000 women in the population which, when age-standardised 
to allow analysis of trends and differentials, equates to an incidence rate of 113.5.  
Of the 13,668 new cases, 7,022 (51.4%) were in women aged 50–69, equivalent to 291.4 new 
cases for every 100,000 women in the population. When age-standardised to allow analyses 
of trends and differentials, this equates to an incidence rate of 288.2 for women aged 50–69. 
Box 7.1: How many breast cancers were detected through BreastScreen Australia? 
It is estimated that 43% of invasive breast cancers diagnosed in women aged 50–69, and 32%  
of breast cancers in women aged 40 and over, were detected through BreastScreen Australia  
in 2009. 
In the broader context of cancers diagnosed in Australian women, breast cancer was the 
most commonly diagnosed cancer (excluding basal cell and squamous cell carcinoma of the 
skin) in Australian women in 2009, comprising 27.4% of all cancers diagnosed in women that 
year, as well as being the most prevalent.  
The mean age at first diagnosis was 60.6, and the risk of being diagnosed with breast cancer 
was 1 in 11 by age 75 and 1 in 8 by age 85. 
Invasive breast cancer incidence trends 
The number of new breast cancer cases in women aged 50–69 has almost tripled during the 
27 years, from 2,456 new cases in 1982 (the year in which national incidence data were first 
available) to 7,022 in 2009 (Figure 7.1; BreastScreen Australia monitoring report 2010–2011: 
supplementary data tables, Table S7.1). 
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For all age groups combined, the overall increase in the number of new cases of invasive 
breast cancer more than doubled from 5,317 in 1982 to 13,668 in 2009, an increase of 157% 
(BreastScreen Australia monitoring report 2010–2011: supplementary data tables, Table S7.1). 
Table 7.1: Incidence of invasive breast cancer, 1982 to 2009 
   Age group (years) 
Year of diagnosis All ages  <50 50–69 70+ 
1982 81.1   33.8 175.4 250.0 
1983 80.8   34.5 167.2 258.1 
1984 83.9   34.2 180.1 268.0 
1985 84.8   34.9 181.9 267.6 
1986 85.4   33.3 185.2 280.3 
1987 91.6   38.3 198.1 281.0 
1988 90.0   36.9 195.3 279.8 
1989 94.0   37.5 209.5 288.8 
1990 95.3   38.4 210.6 293.6 
1991 100.7   38.8 231.0 305.8 
1992 98.4   39.8 222.9 290.3 
1993 105.5   40.3 251.4 302.8 
1994 114.5   41.3 283.7 323.8 
1995 115.9   41.6 286.2 332.8 
1996 109.6   40.2 270.0 308.9 
1997 111.9   39.6 278.3 320.7 
1998 115.0   40.5 289.2 324.7 
1999 111.6   39.1 288.0 300.2 
2000 116.2   40.9 296.5 318.2 
2001 117.8   40.7 305.8 318.1 
2002 117.6   41.4 305.2 310.9 
2003 112.7   41.3 286.6 299.0 
2004 113.7   40.7 289.7 307.1 
2005 111.8   42.7 280.9 289.8 
2006 113.2   42.1 288.8 292.8 
2007 109.9   41.2 275.4 292.9 
2008 116.0   42.6 295.3 306.0 
2009 113.5  40.8 288.2 307.5 
Note: Rates are the number of new cases of invasive breast cancer per 100,000 women and age-standardised to the Australian population at  
30 June 2001. 
Source: AIHW Australian Cancer Database. 
BreastScreen Australia began in 1991. While the age-standardised incidence rate for women 
aged 50–69 had been increasing steadily before this—from 175.4 new cases per 
100,000 women in 1982 (the first year for which data are available) to 210.6 in 1990—
incidence increased more sharply from 231.0 in 1991 to a peak of 305.8 new cases per 
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100,000 women in 2001 (Table 7.1; Figure 7.1). Thereafter, the rate decreased between 2002 
and 2009 from 305.2 to 288.2 new cases per 100,000, respectively (Figure 7.1).  
 
Note: Rates are the number of new cases of invasive breast cancer per 100,000 women and age-standardised to the Australian population  
at 30 June 2001. 
Source: AIHW Australian Cancer Database. 
Figure 7.1: Incidence of invasive breast cancer in women aged 50–69, 1982 to 2009 
Invasive breast cancer incidence trends by age 
When comparing trends in the incidence of invasive breast cancer across broad age groups, 
the pattern for women aged 50–69 appears to be mirrored in that for women aged 70 and 
over (Figure 7.2). While incidence was historically highest in women aged 70 and over, 
incidence has been indistinguishable from that in women aged 50–69 since 2005. Incidence 
for women aged under 50 remained steady at between about 39 and 43 new cases per 
100,000 women between 1991 and 2009.  
It is also interesting to note that, in 2009, new cases of invasive breast cancer diagnosed in 
women aged 50–69 comprised 51.4% of all invasive breast cancers. This is an increase from 
48.1% in 1999, and 43.6% in 1989. BreastScreen Australia targets women aged 50–69. 
For invasive breast cancer diagnosed in 2009, analysis of 5-year age groups reveals that 
incidence was highest for women aged 65–69, at 376.9 new cases per 100,000 women  
(Figure 7.3; Table 7.2). 
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Note: Rates are the number of new cases of invasive breast cancer per 100,000 women and age-standardised to the Australian 
population at 30 June 2001. 
Source: AIHW Australian Cancer Database. 
Figure 7.2: Incidence of invasive breast cancer, by age, 1982 to 2009 
 
 
Source: AIHW Australian Cancer Database. 
Figure 7.3: Age-specific incidence rates for invasive breast cancer, by age, 1989, 1999 and 2009  
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Table 7.2: Age-specific incidence of invasive breast cancer, by age, 2009  
 Age group (years) 
 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+ 
New cases 904 1,462 1,703 1,754 1,912 1,653 1,112 893 792 724 
Crude rate 117.5 184.1 234.3 266.2 326.7 376.9 313.2 301.4 318.6 292.2 
Note: Rates are the number of new cases of invasive breast cancers per 100,000 women. 
Source: AIHW Australian Cancer Database. 
Figure 7.3 shows age-specific incidence rates for invasive breast cancer for 1989, 1999 and 
2009. While women aged 65–69 had the highest incidence of invasive breast cancer in 2009 
(at 376.9 cases per 100,000 women), the 1999 trend across 5-year age groups was notably 
flatter with the incidence rate between 298 and 324 new cases per 100,000 women for women 
aged 60–64 and older. 
Going back another 10 years to 1989—before BreastScreen Australia began—incidence was 
lower than in 1999 and 2009 for all age groups from 45–49 to 80–84. Only for women aged 85 
and over was the incidence rate higher. 
Invasive breast cancer incidence by state and territory 
In 2004–2008, the incidence of invasive breast cancer for women aged 50–69 was relatively 
stable across states and territories, with most around the national rate of 286.1 new cases per 
100,000 women (Table 7.3; Figure 7.4).  
The exceptions were the least populated states and territories—the Australian Capital 
Territory, with a higher incidence of 321.1 new cases per 100,000 women, and the Northern 
Territory, with a lower incidence of 209.0. It should be noted, however, that the data for the 
two least-populated jurisdictions are subject to variation due to smaller numbers, even with 
5 years of data combined. 
Table 7.3: Incidence of invasive breast cancer, women aged 50–69, by state and territory, 2004–2008 
 NSW Vic  Qld WA SA Tas ACT NT Australia  
New cases 10,568 7,721 6,355 3,022 2,666 780 550 163 31,825 
AS rate 287.7 281.2 292.2 280.5 293.2 266.6 321.1 209.0 286.1 
95% CI 282.2–
293.3 
274.9–
287.5 
285.1–
299.5 
270.6–
290.7 
282.2–
304.6 
248.1–
286.0 
294.7–
349.2 
177.2–
244.8 
283.0–
289.3 
Note: Rates are the number of new cases of invasive breast cancer per 100,000 women and age-standardised to the Australian population at 
30 June 2001. 
Source: AIHW Australian Cancer Database. 
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Note: Bars on columns represent 95% confidence intervals. 
Source: AIHW Australian Cancer Database. 
Figure 7.4: Incidence of invasive breast cancer, women aged 50–69, by state and territory, 
1999–2003 and 2004–2008 
Invasive breast cancer incidence by remoteness area 
The incidence of invasive breast cancer in women aged 50–69 decreased with increasing level 
of remoteness. In 2004–2008, incidence decreased from 288.0 new cases per 100,000 women in 
Major cities to 186.4 in Very remote locations (Figure 7.5A; Table 7.4). 
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Source: AIHW Australian Cancer Database. 
Figure 7.5: Incidence of invasive breast cancer in women aged 50–69, by remoteness area (A) and 
by socioeconomic status (B), 2004–2008  
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Table 7.4: Incidence of invasive breast cancer, women aged 50–69, by remoteness area, 2004–2008 
 Major cities Inner regional Outer regional Remote Very remote Australia 
New cases  21,264 6,968 3,014 384 115 31,825 
AS rate 288.0 285.9 274.6 264.0 186.4 286.1 
95% CI 284.1–291.9 279.2–292.8 264.9–284.6 237.9–291.5 153.0–223.2 283.0–289.3 
Notes  
1. Rates are the number of new cases of invasive breast cancer per 100,000 women and age-standardised to the Australian population at  
30 June 2001. 
2. Remoteness areas were assigned using the woman’s residential postcode according to the Australian Standard Geographical Classification 
for 2006. Not all postcodes can be assigned to a remoteness area therefore, categories do not add to Australia. 
Source: AIHW Australian Cancer Database. 
Invasive breast cancer incidence by socioeconomic status 
In 2004–2008, the incidence of invasive breast cancer in women aged 50–69 increased 
progressively with increasing socioeconomic status. Consistent with this, women living in 
areas with the highest socioeconomic status had a significantly higher invasive breast cancer 
incidence rate (304.7 cases per 100,000 women) than women living in areas with the lowest 
socioeconomic status (265.7 cases per 100,000 women) (Table 7.5; Figure 7.5B).  
Table 7.5: Incidence of invasive breast cancer, women aged 50–69, by socioeconomic status,  
2004–2008 
 1(Lowest) 2 3 4 5 (Highest) Australia 
New cases  6,046 6,407 6,281 6,187 6,822 31,825 
AS rate 265.7 279.5 284.9 292.3 304.7 286.1 
95% CI 259.0–272.5 272.7–286.5 277.9–292.1 285.0–299.7 297.5–312.1 283.0–289.3 
Notes 
1. Rates are the number of new cases of invasive breast cancer per 100,000 women and age-standardised to the Australian population at  
30 June 2001. 
2. Socioeconomic status was assigned using the woman’s residential postcode according to the Socioeconomic Index for Areas (SEIFA) Index 
of Relative Socioeconomic Disadvantage for 2006; 1 (lowest socioeconomic group) corresponds to the most disadvantaged socioeconomic 
status and 5 (highest socioeconomic group) to the least disadvantaged socioeconomic status. Not all postcodes could be assigned to a 
socioeconomic category, therefore, categories do not add to Australia. 
Source: AIHW Australian Cancer Database. 
Invasive breast cancer incidence by Indigenous status 
The collection of reliable information by the state and territory cancer registries on the 
Indigenous status of individuals diagnosed with cancer is problematic. This is because 
primary cancer diagnosis information is sourced from pathology forms which, in most states 
and territories, currently do not have the capacity to record this information. The registries 
collect information about Indigenous status from additional sources such as hospital records 
and death records, which affects the completeness and correctness of these data. 
This means that reliable national data on the incidence of cancer for Aboriginal and Torres 
Strait Islander Australians are not available, because in some jurisdictions the level of 
identification of Indigenous status is not considered sufficient to enable analyses.  
Over the 5-year period 2004–2008, data for New South Wales, Queensland, Western 
Australia and the Northern Territory were considered of sufficient quality and have been 
used to examine the incidence of invasive breast cancer by Indigenous status.  
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While the majority (84%) of Aboriginal and Torres Strait Islander people reside in these four 
jurisdictions (ABS 2009), the degree to which these data are representative of data for all 
Aboriginal and Torres Strait Islander people in Australia is unknown. Further, even for these 
jurisdictions, the level of missing data on Indigenous status for invasive breast cancers 
diagnosed in 2004–2008 was 8.9%. This means that for about for 1 in 9 women diagnosed 
with invasive breast cancer over the 5-year period 2004–2008, information on Indigenous 
status was not recorded. This level of missing data should be taken into account when 
interpreting these data. However, it is considered that the benefits of reporting these 
incidence data outweigh the risk of including imperfect and incomplete data. 
In 2004–2008, for women in New South Wales, Queensland, Western Australia and the 
Northern Territory, Aboriginal and Torres Strait Islander women aged 50–69 had a 
significantly lower incidence of invasive breast cancer (213.3 new cases per 100,000 women) 
compared with non-Indigenous women from these states and territories (262.9 new cases per 
100,000 women) (Figure 7.6; Table 7.6). 
This was also true for Aboriginal and Torres Strait Islander women of all ages, with an  
age-standardised incidence rate of 82.1 new cases per 100,000 women compared with the 
non-Indigenous rate of 103.6 (see BreastScreen Australia monitoring report 2010–2011: 
supplementary data tables). Despite this lower rate, breast cancer is the most commonly 
diagnosed cancer for Aboriginal and Torres Strait Islander women in New South Wales, 
Queensland, Western Australia and the Northern Territory. 
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Notes  
1. Some states and territories use an imputation method for determining Indigenous cancers that may lead to differences 
between these data and those shown in jurisdictional cancer incidence reports. 
2. The rates were age-standardised to the Australian population as at 30 June 2001. 
3 The bars on the columns represent 95% confidence intervals. 
Source: AIHW Australian Cancer Database. 
Figure 7.6: Incidence of breast cancer (New South Wales, Queensland, Western Australia 
and the Northern Territory), by Indigenous status, women 50–69, 2004–2008 
Table 7.6: Incidence of breast cancer (New South Wales, Queensland, Western Australia and the 
Northern Territory) by Indigenous status, women aged 50–69, 2004–2008 
 Aboriginal and Torres Strait Islander
(a)
 Non-Indigenous
(a)
 Australia 
New cases 228 18,122 31,825 
Crude rate 205.7 264.5 287.9 
AS rate  213.3 262.9  286.1 
95% CI 186.1–243.2 259.1–266.8 283.0–289.3 
(a)  ‘Aboriginal and Torres Strait Islander’ and ‘Non-Indigenous’ are for New South Wales, Queensland, Western Australia and the Northern 
Territory only. Data from these jurisdictions were considered to have adequate levels of Indigenous identification in cancer registration data 
at the time this report was prepared.  
Notes 
1. Some states and territories use an imputation method for determining Indigenous cancers that may lead to differences between these data 
and those shown in jurisdictional cancer incidence reports. 
2. Crude rates are the number of new cases of invasive breast cancer per 100,000 women. 
3. Age-standardised rates are the number of new cases of invasive breast cancer per 100,000 women, age-standardised to the Australian 
population at 30 June 2001. 
Source: AIHW Australian Cancer Database.   
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Indicator 7b Ductal carcinoma in situ incidence 
What you need to know about DCIS incidence 
Definition: The number of new cases of ductal carcinoma in situ (DCIS) per 100,000 
estimated resident female population in a 12-month period. 
Rationale: DCIS incidence data provide information about the underlying level of DCIS in 
Australia. DCIS was rarely detected before breast screening was introduced. Since the 
introduction of screening mammography, detection of DCIS has increased. Annual 
monitoring of these data with various stratifications (such as age or location) may reveal 
findings of concern or positive trends that can be used to inform BreastScreen Australia as 
well as broader policies for DCIS in Australian women. 
Guide to interpretation: These data include both screen-detected DCIS cases (through 
BreastScreen Australia) and DCIS cases detected outside the screening program. 
Incidence data are reported per 100,000 women in the population. 
Incidence of DCIS by state and territory is reported over a 5-year instead of a 12-month 
period to improve the stability and comparability of rates due to the small number of new 
cases in less-populated areas. Further, to produce comparable rates from the relatively small 
number of DCIS cases, incidence of DCIS is reported by 10-year age groups. Unlike data for 
Indicators 1 to 6, DCIS incidence data are presented for women aged 50–69 years and for all 
Australian women (unlike Indicators 1–6, this includes women under 40). 
State and territory cancer registries are the source of DCIS incidence data. 
The most recent incidence of DCIS data are for new cases diagnosed in 2008.  
What the data tell us about DCIS incidence 
 Trend 
Incidence of DCIS for women aged 50–69 increased over time from 29.9 new cases per 
100,000 women in 1996 to a peak of 45.7 new cases in 2001, thereafter remaining steady at 
about 42 to 46 new cases per 100,000 women. In 2008, the incidence in women aged 50–69 
was 45.6 new cases per 100,000 women. 
 
2008 
For women aged 50–69, there were 1,075 new cases of DCIS, or 45.6 new cases per 100,000 
women. In the same year, there were 1,673 new cases, or 14.3 new cases per 100,000, for 
women of all ages.  
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More information about DCIS 
DCIS is a non-invasive tumour arising from the lining of the ducts that carry milk from the 
milk-producing lobules to the nipple. Cell changes seen in DCIS are similar to those in 
invasive breast cancer. However, unlike invasive breast cancer, DCIS does not invade 
surrounding breast tissue, and is instead contained entirely within the milk duct. 
Incidence of DCIS measures the number of new cases of DCIS diagnosed each year. DCIS is 
presently not included in the Australian Cancer Database; however, state and territory 
cancer registries have been routinely collecting data on DCIS for more than 10 years, and are 
the source of DCIS incidence data reported here. Similar to invasive breast cancer incidence 
data, DCIS data refer to the number of new cases diagnosed and not the number of women 
diagnosed. Further, if a woman is diagnosed with DCIS and invasive breast cancer, only the 
more serious diagnosis of invasive breast cancer is counted.  
Detailed analyses 
DCIS incidence 2008 
There were 1,673 new cases of DCIS in Australian women in 2008. This is equivalent to 
15.5 new cases per 100,000 women in the population, which, when age-standardised to allow 
analyses of trends and differentials, equates to an incidence rate of 14.3. 
Of the 1,673 new cases, 1,075 were in women aged 50–69, the target population of 
BreastScreen Australia. These 1,075 new cases represent 64.3% of all DCIS cases in that year 
and 45.9 new cases for every 100,000 women in the population. When age-standardised, this 
equates to an incidence rate of 45.6.  
Box 7.2: How many DCIS cases were detected through BreastScreen Australia? 
In 2008, it was estimated that 76% of DCIS cases diagnosed in women aged 50–69, and 64% 
of DCIS cases in women aged 40 or over, were detected through BreastScreen Australia.  
DCIS incidence trends 
Incidence of DCIS has increased over time (Table 7.7). For women aged 50–69, it has 
increased steadily from 29.9 new cases per 100,000 women in 1996 to a peak of 45.7 new 
cases in 2001, thereafter remaining steady at about 42 to 46 new cases per 100,000 women. In 
2008, the incidence in women aged 50–69 was 45.6 new cases per 100,000. 
Table 7.7: Incidence of DCIS, women aged 50–69, 1996 to 2008 
 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
AS 
rate 29.9 33.3 37.0 37.9 41.0 45.7 42.6 41.9 44.3 43.4 43.1 43.4 45.6 
95% 
CI 
27.3–
32.7 
30.6–
36.2 
34.2–
40.0 
35.1–
40.8 
38.1–
44.0 
42.7–
48.9 
39.7–
45.6 
39.1–
44.8 
41.5–
47.2 
40.6–
46.3 
40.4–
45.9 
40.7–
46.2 
42.9–
48.4 
Note: Rates are the number of new cases of DCIS per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
Source: AIHW analysis of state and territory cancer registry data. 
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DCIS incidence by age 
In 2008, the highest incidence of DCIS was for women aged 60–69, with 52.5 new cases per 
100,000 women; this was followed by women aged 50–59, with 41.1 (Table 7.8). 
Table 7.8: Age-specific incidence rates for DCIS, by age, 2008  
 Age group (years) 
 40–49 50–59 60–69 70+ 
New cases 299 559 516 246 
Crude rate 19.3 41.1 52.5 21.9 
Note: Rates are the number of new cases of DCIS per 100,000 women. 
Source: AIHW analysis of state and territory cancer registry data. 
DCIS incidence by state and territory 
In 2004–2008, the incidence of DCIS across the states and territories for women aged 50–69 
varied between 33.0 and 54.2 new cases per 100,000 women (Table 7.9), although caution 
should be used when interpreting rates from small numbers such as these. There was little 
change in the DCIS incidence rates between 1999–2003 and 2004–2008 (Figure 7.7). 
 
 
Note: Bars on columns represent 95% confidence intervals. 
Source: AIHW analysis of state and territory cancer registry data. 
Figure 7.7: Incidence of DCIS in women aged 50–69, by state and territory, 1999–2003 and 
2004–2008 
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Table 7.9: Incidence of DCIS, women aged 50–69, by state and territory, 2004–2008 
 NSW Vic  Qld WA SA Tas ACT NT Australia  
New cases 1,485 1,232 1,021 584 328 121 76 26 4,873 
AS rate 40.7 45.0 47.1 54.2 36.3 41.8 44.8 33.0 44.0 
95% CI 38.6–42.8 42.5–47.6 44.2–50.1 49.9–58.8 32.5–40.4 34.7–50.0 35.3–56.1 21.3–48.6 42.7–45.2 
Note: Rates are the number of new cases of DCIS per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
Source: AIHW analysis of state and territory cancer registry data. 
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Indicator 8 Mortality 
What you need to know about mortality 
Definition: The number of deaths from breast cancer per 100,000 estimated resident female 
population in a 12-month period. 
Rationale: BreastScreen Australia aims to reduce mortality from breast cancer. 
Guide to interpretation: These data include mortality from all breast cancers, whether or not 
they were detected through BreastScreen Australia. Mortality from breast cancer refers to 
mortality from invasive breast cancer, although the term ‘invasive’ has been dropped from 
this chapter as it is not required to distinguish it from DCIS. 
Mortality data are reported per 100,000 women in the population. 
Mortality from breast cancer by state and territory, remoteness area, socioeconomic status 
and Indigenous status is reported over a 5-year period to improve the stability and 
comparability of rates due to the small number of deaths in less populated areas and in 
Aboriginal and Torres Strait Islander women. 
The National Mortality Database is the source of breast cancer mortality data.  
The most recent data for mortality from breast cancer (when preparing this report) are 
deaths in 2010.  
What the data tell us about mortality 
 Trend 
Mortality decreased from 68.2 deaths per 100,000 women in 1991, when BreastScreen 
Australia commenced, to 43.3 per 100,000 women in 2010. 
 
2010 
In 2010, there were 1,098 deaths from breast cancer in women aged 50–69 (the target 
population of BreastScreen Australia), or 43.3 deaths per 100,000 women. There were 
2,840 deaths, or 21.6 deaths per 100,000 women, for women of all ages. 
 
2006–2010 
Death rates did not differ between Aboriginal and Torres Strait Islander women and  
non-Indigenous women (54.5 and 45.4 per 100,000 women, respectively, for the 2006–2010 
period).  
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More information about mortality 
Mortality data are some of the most comprehensively collected national data in Australia. 
Registration of death is a legal requirement in Australia and, as a result, the data set is 
virtually complete. Registration of deaths is the responsibility of the Registrar of Births, 
Deaths and Marriages in each state and territory. The mortality data used in this report were 
provided by these registries and the National Coroners Information System, and coded by 
the ABS. These data are maintained at the AIHW in the National Mortality Database.  
Mortality from breast cancer measures the number of deaths each year for which breast 
cancer was the underlying cause of death. Analyses are based on the year of death, except for 
2010 (the latest year for which mortality data were available at the time of printing), which is 
based on year of registration of death. Cause of death data for 2009 are revised and data for 
2010 are preliminary, and both are subject to revision. About 5% of deaths are not registered 
until the year following the death (ABS 2007). 
Note that no adjustments were made to 2010 data regarding late registrations in Queensland.  
Detailed analyses 
Mortality in 2010 
In 2010, there were 2,840 deaths from breast cancer in Australian women. This is equivalent 
to 25.4 deaths for every 100,000 women in the population, which, when age-standardised to 
allow analysis of trends and differentials, equates to a mortality rate of 21.6. 
Of the 2,840 deaths, 1,098 were in women aged 50–69, the target population of BreastScreen 
Australia. These 1,098 deaths represent 38.7% of all breast cancer deaths in that year, and 
44.3 deaths for every 100,000 women aged 50–69 in the population. When age-standardised 
to allow analysis of trends and differentials, this equates to a mortality rate of 43.3 deaths per 
100,000 women for women aged 50–69. 
In the broader context of cancer deaths in Australian women, breast cancer was the second 
most common cancer causing death in Australian women in 2010 (behind lung cancer), 
comprising 15.3% of all cancer deaths in women that year. In 2010, the mean age of death for 
women was 69.0 years, and the risk of dying from breast cancer was 1 in 67 by age 75 and 
1 in 39 by age 85. 
Mortality trends 
Mortality from breast cancer has decreased over time in Australia.  
For women aged 50–69, mortality remained relatively steady between 1982 and 1990 (the 
year before BreastScreen Australia began).  
However, it decreased from 68.2 deaths per 100,000 women in 1991, when BreastScreen 
Australia started, to 43.3 per 100,000 in 2010 (the latest year for which data are available) 
(Table 8.1; Figure 8.1). This represents a decrease of 36.5% from the 1991 mortality rate to that 
observed in 2010 for women aged 50–69. 
The decrease in mortality in women aged 50–69 has been attributed, in part, to the early 
detection of breast cancer through BreastScreen Australia, along with advances in the 
management and treatment of breast cancer (BreastScreen Australia EAC 2009a). 
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Note: Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted.  
Source: AIHW analysis of the National Mortality Database. 
Figure 8.1: Mortality from breast cancer, women aged 50–69, 1982 to 2010 
Breast cancer mortality by age 
 
Notes 
1. Rates are the number of deaths from breast cancer per 100,000 women. 
2.  Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted. 
Source: AIHW analysis of the National Mortality Database. 
Figure 8.2: Mortality from breast cancer, by age, 1982 to 2010 
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When comparing trends across broad age groups, it is evident that breast cancer mortality 
affects more older women than younger women (Figure 8.2). Further, mortality in women 
aged 50–69 appears to mirror that for women aged 70 and over. Further (although difficult to 
see in Figure 8.2), the general trend described for women aged 50–69 was also true for 
women aged under 50. For these younger women, after a period of relative stability, the 
mortality rate fell from 8.0 deaths per 100,000 women in 1991 to 4.4 in 2010 (Table 8.1). 
Table 8.1: Mortality rates from breast cancer, 1982 to 2010 
  Age group (years) 
Year All ages <50 50–69 70+ 
1982 30.4 7.6 66.9 130.2 
1983 30.2 7.1 69.9 126.8 
1984 31.6 8.0 69.2 136.6 
1985 31.2 8.4 68.8 128.9 
1986 29.9 7.7 66.6 125.6 
1987 31.1 7.8 69.4 132.4 
1988 31.2 7.3 69.6 136.3 
1989 31.6 8.2 69.0 135.5 
1990 30.6 7.5 68.7 130.5 
1991 31.3 8.0 68.2 134.4 
1992 29.3 7.9 61.2 129.4 
1993 30.8 7.1 68.8 135.1 
1994 30.8 7.6 66.7 135.5 
1995 29.6 6.6 66.4 130.8 
1996 28.7 7.2 62.6 124.8 
1997 27.8 7.2 60.6 118.6 
1998 26.4 6.4 56.6 118.1 
1999 25.5 6.4 55.8 110.1 
2000 24.7 5.9 51.7 114.7 
2001 24.8 5.8 52.3 115.4 
2002 25.0 5.3 56.5 111.9 
2003 24.7 5.5 54.1 111.9 
2004 23.7 5.3 51.8 108.1 
2005 23.6 5.5 51.6 105.6 
2006 22.2 4.5 47.4 106.8 
2007 22.4 4.5 47.6 108.4 
2008 22.1 5.1 46.5 103.8 
2009 21.9 4.7 46.0 106.0 
2010 21.6 4.4 43.3 109.9 
Notes 
1.  Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
2.  Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted. 
Source: AIHW National Mortality Database. 
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For all age groups combined, mortality from breast cancer fell from 31.3 deaths per 100,000 
women in 1991, when BreastScreen Australia was introduced, to 21.6 deaths per 100,000 
women in 2010 (Table 8.1). 
In 2010, deaths from breast cancer in women aged 50–69 comprised 38.7% of all breast cancer 
deaths. This has changed little from the 39.6% of breast cancer deaths in 1997, but represents 
a fall from the 44.0% of all breast cancer deaths in 1987. 
Analysis of 5-year age groups reveals that, in 2010, mortality increased with age, from 
12.3 deaths per 100,000 women aged 40–44 to 207.1 for women aged 85 and over (Table 8.2).  
Table 8.2: Age-specific mortality rates for breast cancer, 2010 
 Age group (years) 
 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+ 
Deaths 96 174 211 279 312 296 272 270 327 535 
Crude rate 12.3 21.9 28.4 41.7 51.3 64.5 74.2 91.2 130.3 207.1 
Notes 
1. Rates are the number of deaths from breast cancer per 100,000 women.  
2. Mortality data for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted. 
Source: AIHW National Mortality Database. 
 
The trend described in 2010 was similar to that for both 10 and 20 years earlier—in 2000 and 
1990, respectively (Figure 8.3). 
 
Notes 
1. Rates are the number of deaths from breast cancer per 100,000 women. 
2. Mortality data for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted. 
Source: AIHW National Mortality Database. 
Figure 8.3: Age-specific mortality rates for breast cancer, 1990, 2000 and 2010 
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Mortality from breast cancer by state and territory 
In 2006–2010, mortality from breast cancer for women aged 50–69 was relatively similar 
across states and territories to the national rate of 46.1 deaths per 100,000 women (Table 8.3; 
Figure 8.4). 
Table 8.3: Mortality from breast cancer, women aged 50–69 and women of all ages, by state and 
territory, 2006–2010 
 NSW Vic Qld WA SA Tas ACT NT Australia 
50–69 years          
Deaths  1,788 1,366 1,053 515 501 148 83 32 5,486 
AS rate  45.8 46.5 44.7 44.2 52.2 47.8 45.5 37.7 46.1 
95% CI 43.7–48.0 44.1–49.1 42.0–47.5 40.5–48.2 47.7–57.0 40.3–56.1 36.2–56.4 25.5–53.6 44.9–47.3 
All ages          
Deaths  4,679 3,524 2,431 1,219 1,242 363 201 57 13,716 
AS rate  22.4 22.4 20.7 21.0 23.4 22.4 23.7 17.3 22.0 
95% CI 21.7–23.0 21.6–23.1 19.9–21.6 19.8–22.2 22.1–24.8 20.1–24.9 20.5–27.2 12.5–23.1 21.7–22.4 
Notes 
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
2.  Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted; state of 
usual residence used.  
Source: AIHW National Mortality Database. 
 
Notes 
1. Bars on columns represent 95% CIs.  
2.  Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not 
adjusted; state of usual residence used. 
Source: AIHW National Mortality Database. 
Figure 8.4: Mortality from breast cancer, women aged 50–69, by state and territory, 2001–2005 and 
2006–2010 
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Mortality from breast cancer by remoteness area 
In 2006–2010, mortality from breast cancer for women aged 50–69 was relatively similar 
across remoteness areas (Table 8.4; Figure 8.5).  
Table 8.4: Mortality from breast cancer, by remoteness area, women aged 50–69 and women of all 
ages, 2006–2010 
 Major cities Inner regional Outer regional Remote Very remote Australia 
50–69 years       
Deaths 3,596 1,260 523 74 26 5,486 
AS rate 45.7 47.7 44.2 49.1 41.9 46.1 
95% CI 44.3–47.3 45.1–50.4 40.5–48.2 38.4–61.4 26.8–61.0 44.9–47.3 
All ages       
Deaths 9,154 3,066 1,277 145 52 13,716 
AS rate 21.9 22.6 21.9 20.9 19.2 22.0 
95% CI 21.4–22.3 21.8–23.4 20.7–23.2 17.5–24.5 14.1–25.4 21.7–22.4 
Notes 
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
2.  Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted.  
3. Remoteness areas were assigned using the woman’s residential postcode according to the Australian Standard Geographical Classification 
for 2006. Not all postcodes can be assigned to a remoteness area therefore, categories do not add to Australia. 
Source: AIHW National Mortality Database. 
 
Notes 
1. Bars on columns represent 95% confidence intervals.  
2.  Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not 
adjusted. 
Source: AIHW analysis of BreastScreen Australia data. 
Figure 8.5: Mortality from breast cancer, by remoteness area, women aged 50–69, 2001–2005 and 
2006–2010 
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Mortality from breast cancer by Indigenous status 
Information on Indigenous status on the National Mortality Database is considered of 
sufficient quality to analyse the years 2006 to 2010 for five jurisdictions—New South Wales, 
Queensland, Western Australia, South Australia and the Northern Territory. The majority 
(89%) of Aboriginal and Torres Strait Islander people reside in these five jurisdictions 
(ABS 2009). 
Note that, as the jurisdictions for which mortality by Indigenous status can be estimated is 
different from those for which incidence by Indigenous status can be estimated, no direct 
comparisons between incidence and mortality are made. 
Mortality from breast cancer by Indigenous status for New South Wales, Queensland, 
Western Australia, South Australia and the Northern Territory is presented for the most 
recent 5-year period, 2006–2010. 
These data show that in 2006–2010, mortality from breast cancer did not differ between 
Indigenous women and non-Indigenous women.  
In 2006–2010, mortality from breast cancer in Aboriginal and Torres Strait Islander women 
aged 50–69 in the five jurisdictions combined was 54.5 per 100,000 women, compared with 
the non-Indigenous rate of 45.4 in these jurisdictions (Figure 8.6, Table 8.5).  
Mortality for women of all ages was 27.4 deaths per 100,000 women for Aboriginal and 
Torres Strait Islander women compared with the non-Indigenous rate of 21.6 (Table 8.5). 
Table 8.5: Mortality from breast cancer (New South Wales, Queensland, Western Australia, South 
Australia and the Northern Territory) by Indigenous status, women aged 50–69 and women of all 
ages, 2006–2010 
 Aboriginal and Torres Strait Islander
(a)
 Non-Indigenous
(a)
 Australia 
50–69 years    
Deaths 69 3,784 5,486 
Crude rate 52.8 46.1 46.8 
AS rate 54.5 45.4 46.1 
95% CI 42.2–69.1 43.9–46.8 44.9–47.3 
All ages    
Deaths 137 9,407 13,716 
Crude rate 11.4 25.3 25.4 
AS rate 27.4 21.6 22.0 
95% CI 22.3–33.1 21.2–22.0 21.7–22.4 
(a)  ‘Aboriginal and Torres Strait Islander’ and ‘Non-Indigenous’ are for New South Wales, Queensland, Western Australia, South Australia and 
the Northern Territory only. Data from these jurisdictions were considered to have adequate levels of Indigenous identification in cancer 
mortality data at the time this report was prepared.  
Notes 
1. Crude rates are the number of deaths from breast cancer per 100,000 women. 
2. Age-standardised rates are the number of deaths from breast cancer per 100,000 women, age-standardised to the Australian population at 
30 June 2001. 
3.  Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted. 
Source: AIHW National Mortality Database. 
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Notes  
1. Bars on columns represent 95% confidence intervals. 
2. ‘Aboriginal and Torres Strait Islander’ and ‘non-Indigenous’ are for New South Wales, Queensland, Western Australia 
 South Australia and the Northern Territory only. ‘Australia’ includes all states and territories.  
3. Age-standardised rates are the number of deaths from breast cancer per 100,000 women, age-standardised to the Australian 
population at 30 June 2001. 
4. Mortality data for 2009 are revised and for 2010 are preliminary and are subject to further revision; 2010 data are not adjusted. 
Source: AIHW National Mortality Database. 
Figure 8.6: Mortality from breast cancer (New South Wales, Queensland, Western Australia, 
South Australia and the Northern Territory), by Indigenous status, women aged 50–69,  
2006–2010 
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Appendix A Additional data 
 
Notes 
1. The symbols represent the average 2010 and 2011 ABS estimated resident population for women aged 50–69. 
2. The lighter shaded symbols represent the proportion of women screened in 2010–2011. 
3. The darker shaded symbols represent the proportion of women recalled to assessment in 2010. 
4. The single darkest symbol (set within a screened box) represents the proportion of women who have an invasive breast cancer detected 
through BreastScreen Australia. 
Source: AIHW analysis of BreastScreen Australia data. 
Figure A1: Women in BreastScreen Australia aged 50–69, 2010–2011 
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Appendix B BreastScreen Australia 
information 
Table B1: Contacts and links for the state, territory and Australian government components of 
BreastScreen Australia 
BreastScreen New South Wales 
Tel: (02) 8374 5777 
Fax: (02) 8374 5699 
E-mail: information@cancerinstitute.org.au 
<www.bsnsw.org.au/>. 
 
BreastScreen Victoria 
Tel: (03) 9660 6888 
Fax: (03) 9662 3881 
E-mail: info@BreastScreen.org.au 
<www.BreastScreen.org.au>. 
 
BreastScreen Queensland 
Tel: (07) 3328 9467 
Fax: (07) 3328 9487 
Email: cssb@health.gov.au 
<www.BreastScreen.qld.gov.au>. 
 
BreastScreen Western Australia 
Tel: (08) 9323 6700 
Fax: (08) 9323 6799 
E-mail: BreastScreenwa@health.wa.gov.au 
<www.BreastScreen.health.wa.gov.au>. 
 
BreastScreen South Australia 
Tel: (08) 8274 7100 
Fax: (08) 8373 4395 
E-mail: BSSAenquiries@health.sa.gov.au 
<www.breastscreensa.sa.gov.au>. 
BreastScreen Tasmania 
Tel: (03) 6216 4300 
Fax: (03) 6216 4326 
E-mail: canscreen@dhhs.tas.gov.au 
<www.dhhs.tas.gov.au/cancerscreening/information_ 
about_breast_screening>. 
BreastScreen ACT 
Tel: (02) 6205 4444 
Fax: (02) 6205 1394 
E-mail: BreastScreen@act.gov.au 
<http://health.act.gov.au/c/health?a=sp&pid=1059452616>. 
 
BreastScreen NT 
Tel: (08) 8922 6449 
Fax: (08) 8922 6440 
E-mail: wcpp.ths@nt.gov.au 
<www.health.nt.gov.au/Womens_Health/Breast_Screen_NT/in
dex.aspx>. 
 
Australian Government Department of Health and Ageing  
cancerscreening@health.gov.au 
 
<www.cancerscreening.gov.au/internet/screening/ 
publishing.nsf/Content/BreastScreen-about>. 
AIHW  
screening@aihw.gov.au <www.aihw.gov.au/breast-cancer-screening/>. 
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BreastScreen Australia definitions 
Target age group 
Women aged 50–69. BreastScreen Australia selects women on the basis of age alone. 
BreastScreen Australia actively targets women aged 50–69 through recruitment strategies 
and reminder letters.  
Indigenous status 
Participation can be reported by Indigenous status because this is recorded on state and 
territory BreastScreen registers. Women who attend for a screening mammogram at a 
BreastScreen Australia service are asked to complete a form that includes personal and 
demographic details, as well as personal and family history of breast cancer. The form also 
includes a question on Indigenous status where the respondent can identify as ‘Aboriginal’, 
‘Torres Strait Islander’, ‘both Aboriginal and Torres Strait Islander’, or ‘neither Aboriginal or 
Torres Strait Islander’. There is an additional ‘not stated’ category for women who choose 
not to answer this question.  
This aligns with the BreastScreen Australia data dictionary (AIHW & DoHA 2005) which 
specifies that ‘Indigenous status’ (currently ‘Indigenous status’ in the dictionary) should be 
coded as: 
• Aboriginal 
• Torres Strait Islander 
• both Aboriginal and Torres Strait Islander 
• not Indigenous, or 
• not stated. 
For the purposes of this report, these categories were amalgamated and the data stratified 
into three categories: 
• Aboriginal and Torres Strait Islander 
• not Indigenous, or 
• not stated. 
While self-reported data are generally a robust source of data on Indigenous status 
(AIHW 2010b), it should be noted that some Aboriginal and Torres Strait Islander women 
may choose not to identify as such when presenting to a BreastScreen Australia service. 
Thus, some Aboriginal and Torres Strait Islander women may be incorrectly assigned 
non-Indigenous status. This means that the analysis based upon Indigenous status should be 
interpreted with caution. 
Aboriginal and Torres Strait Islander women comprise a small proportion of women, both in 
the population and within BreastScreen Australia. Aboriginal and Torres Strait Islanders 
make up about 2.5% of the Australian population, with 1.3% of the 2010 female population 
aged 50–69 estimated to be Aboriginal or Torres Strait Islander, based on estimates in 
Aboriginal and Torres Strait Islander population projections (ABS cat. no. 3238.0) (ABS 2009) 
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Main language spoken at home 
Main language spoken at home is also a self-reported category that is supplied at the time of 
screening. Women who are reported as ‘non-English-speaking’ have reported that they 
speak a language other than English at home, which can be interpreted as indicating ‘active 
ethnicity’. Since a different cultural and linguistic background may present a barrier to 
screening, this self-reported category is used to identify women who may have difficulties 
accessing services due to their cultural or language background. 
The BreastScreen Australia data dictionary (AIHW & DoHA 2005) specifies that ‘main language 
spoken at home’ be coded according to the 4-digit ABS Australian Standard Classification of 
Languages, 1997 (ABS cat. no. 1267.0). This report has collapsed the classification into the 
simple dichotomy of ‘English’ and ‘other language’. 
Although this stratification is reported as ‘main language spoken at home’, practice varies 
between the jurisdictions as to how this information is collected. Thus, in some jurisdictions, 
there may be some lack of comparability with the BreastScreen Australia data dictionary 
definition of ‘main language’. 
Some jurisdictions do not allow for the ‘not stated’ category, which means some women who 
speak a language other than English at home will be incorrectly assigned to the ‘English 
only’ category.  
Tumour size 
Tumour size is the size in millimetres of the malignant lesion, and applies to invasive cancers 
only. For more details, see the definition given in the BreastScreen Australia data dictionary 
(AIHW & DoHA 2005). 
Screening round 
The BreastScreen Australia data dictionary (AIHW & DoHA 2005) distinguishes between a 
woman’s screening round in the national program and her round in the state or territory 
program. The screening round in the jurisdictional program is used for this stratification in 
this report. 
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Appendix C Data sources and 
classifications 
Data sources 
Data used in this report are derived from multiple sources and are summarised below (Table 
C1). All data are based on calendar years.  
Table C1: Data sources for performance indicators in the BreastScreen Australia monitoring report 
series 
Indicator Data source Epoch and latest data available 
1 Participation State and territory 
BreastScreen 
registers 
2 years (to align with recommended screening interval); latest data are for women 
screened in 2010 or 2011 
2 Rescreening State and territory 
BreastScreen 
registers 
1 year; latest data are for women screened in 2008 and 2009 
(27 months needs to have passed since last screen to calculate this indicator) 
3 Recall to 
assessment 
State and territory 
BreastScreen 
registers 
1 year; latest data are for women screened in 2010 and 2011 
4 Invasive breast 
cancer detection 
State and territory 
BreastScreen 
registers 
1 year; latest data are for women screened in 2010 and 2011 
5 DCIS detection State and territory 
BreastScreen 
registers 
1 year; latest data are for women screened in 2010 and 2011 
6 Sensitivity State and territory 
BreastScreen 
registers 
3 years are combined due to small numbers (2005, 2006, and 2007) and (2006, 
2007 and 2008); latest data are for women screened in 2008 and 2009 (2 years 
needs to have passed since last screen to calculate this indicator) 
7a Invasive breast 
cancer incidence 
(ICD-10 C50) 
Australian Cancer 
Database, AIHW  
1 year; latest data are for new cases diagnosed in 2009. The 5 years of incidence 
data from 2004 to 2008 were used for showing breast cancer incidence by 
population subgroup because 2008 is the latest year for which actual data were 
available for all states and territories (see the section Incidence data below).  
7b DCIS incidence  State and territory 
cancer registries 
1 year; latest data are for new cases diagnosed in 2008 
8 Mortality (ICD-9 
174, ICD-10 C50) 
National Mortality 
Database, AIHW 
1 year; latest data are for deaths registered in 2010 
BreastScreen Australia data 
BreastScreen Australia has both national and state and territory components. BreastScreen 
Australia policy is coordinated at the national level, but implementing the program is the 
responsibility of the individual state or territory. Data for participation, rescreening, recall to 
assessment, cancer and DCIS detection, and sensitivity are provided by each state and 
territory BreastScreen program, and then compiled into national figures to allow national 
monitoring of BreastScreen Australia.  
Last year, New South Wales data for participation by main language spoken at home  
(a disaggregation of participation), rescreening, recall to assessment, invasive breast cancer 
detection, DCIS detection, and sensitivity were not available because of issues relating to the 
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implementation of a new business information system in New South Wales. These data have 
since been provided. 
This report presents these data as well as the latest data, except that New South Wales data 
were not available for interval cancers and program sensitivity for 2008 only, 13–24 months 
follow-up.  
Trend data are not provided.  
Incidence data 
Incidence data in this report come from the Australian Cancer Database (formerly the 
National Cancer Statistics Clearing House), a national collection of cancer statistics held and 
operated by the AIHW. The Australian Cancer Database receives data from individual state 
and territory cancer registries on cancers diagnosed in residents of Australia and is the data 
source for reports on national incidence. 
Data have been analysed using the year of cancer diagnosis. This is a more accurate 
reflection of incidence during a particular year than year of registration data. 
Some states and territories use an imputation method for determining Indigenous cancers 
that may lead to differences between these data and those shown in jurisdictional cancer 
incidence reports. 
Constructing the 2009 Australian Cancer Database 
The 1982–2009 data files for New South Wales and the Australian Capital Territory were not 
available for inclusion in the 2009 version of the Australian Cancer Database. An extended 
delay of the receipt of mortality data has meant that New South Wales and the Australian 
Capital Territory have not been able to close off their 2009 data sets. As a consequence, 2009 
cancer data for these jurisdictions are not available for reporting purposes. The 2009 
incidence data for New South Wales and the Australian Capital Territory were estimated by 
the AIHW in consultation with New South Wales and the Australian Capital Territory cancer 
registries. The estimates were combined with the actual data supplied by other state and 
territory cancer registries to form a 1982–2009 national cancer data set. These steps are 
explained in more detail below. 
To construct the 2009 Australian Cancer Database, the 2009 estimates for New South Wales 
and the Australian Capital Territory were combined with the actual data supplied by other 
state and territory cancer registries to form a 1982–2009 national cancer data set. 
Mortality data 
The mortality data used in this report were provided by the Registries of Births, Deaths and 
Marriages, the ABS and the National Coroners Information System. These data are 
maintained at the AIHW in the National Mortality Database. 
The registration of deaths has been compulsory since the mid-1850s and this information is 
registered with the relevant state and territory Registrar of Births, Deaths and Marriages. 
Information on the cause of death is supplied by the medical practitioner certifying the 
death, or by a coroner. State refers to state of residence. Since 1906, the Commonwealth 
Statistician has compiled the information collected by the Registrars and published national 
death information.  
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The information on cause of death is coded by the ABS to an international standard, the 
International Classification of Disease and Related Health Problems, currently the tenth 
version (ICD-10). Deaths are coded to reflect the underlying cause of death.  
Over time, changes have been made to the coding and processing of mortality data that 
affect comparability of the data. For instance, data holdings on cause of death for 1987 to 
1996 were manually coded using the ninth revision of the ICD, while the data for 1997 
onwards were coded to the ICD-10 standard. The change to the coding and processing of 
mortality data introduced a break, in 1997, in the time series.  
In the National Mortality Database, both the year death occurred, and the year it was 
registered, are indicated. For the purposes of this report, mortality data are shown based on 
the year of death, except for the most recent year (namely, 2010) where the number of people 
whose death was registered is used. Previous investigation has shown that the year of death 
and its registration coincide for the most part. However, in some instances, deaths at the end 
of each calendar year may not be registered until the following year. Thus, year of death 
information for the latest available year is generally an underestimate of the actual number 
of deaths that occurred in that year. 
Queensland mortality data by Indigenous status have been adjusted for late registrations in 
2010. More information is available in ABS causes of death for 2010 (ABS cat. no. 3303.0) from 
<www.abs.gov.au>. 
Population data 
The ABS estimated resident female population was used to calculate participation, incidence 
and mortality rates in this report.  
Participation rates were calculated using the average of the estimated resident female 
population for 2-year reporting periods. Denominators for participation rates have been 
calculated using the average of the ABS estimated resident population for 2008 and 2009 and 
other periods. Because the ABS does not calculate the estimated resident population by 
socioeconomic status or language spoken at home, alternative methods were used to 
calculate the denominators for these rates. In the case of language spoken at home, the 
denominator was calculated by applying the age-specific distribution from the language 
question in the 2006 national population Census to the relevant age-specific estimated 
resident population counts. The denominator for rates based on socioeconomic status was 
calculated by applying an ABS concordance between postal area and socioeconomic status to 
the relevant estimated resident population by postal area. 
The average of the ABS projected populations (ABS cat. no. 3238.0) (ABS 2009) for 2009 and 
2010 was used as the denominator for the participation of Aboriginal and Torres Strait 
Islander women. 
The age-standardised rates in this publication were calculated using the total estimated 
resident Australian population at June 2001. 
There may be some variation in published participation rates because of different sources of 
estimated resident population data between national reports and state and territory reports.  
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Classifications 
Age 
The data in this report are either stratified by the age of the woman at the time of screening 
(for the screening data), at the time of diagnosis (for the cancer incidence data) or at the time 
of death (for the cancer mortality data).  
State or territory 
The state or territory reported is the one where screening took place (for the screening data), 
where the diagnosis was made (for the cancer incidence data) or the place of usual residence 
(for the cancer mortality data). 
This means that it is possible for a woman to be double-counted in the screening data. If she 
was screened in one jurisdiction and then screened again less than 2 years later in another, 
both screens may be included in participation. This is expected to have a negligible effect on 
the reported participation. 
Remoteness area 
Remoteness areas are classified according to the ABS’s Australian Standard Geographic 
Classification (ASGC) Remoteness Structure (ABS 2006), which groups geographic areas into 
six categories. These categories, called remoteness areas, are based on Census Collection 
Districts (CDs) and defined using the Accessibility/Remoteness Index for Australia (ARIA). 
This index is a measure of the remoteness of a location from the services provided by large 
towns or cities. Accessibility is judged purely on distance to one of the metropolitan centres. 
A higher ARIA score denotes a more remote location. The six remoteness areas of the ASGC 
Remoteness Structure are listed in the table below (Table C2); the sixth area—‘migratory’— is 
not used in this report.  
Table C2: Remoteness areas for the ASGC 
Remoteness area of Australia Collection districts within region 
Major cities  CDs with an average ARIA index value of 0 to 0.2 
Inner regional  CDs with an average ARIA index value greater than 0.2 and less than or equal to 2.4 
Outer regional CDs with an average ARIA index value greater than 2.4 and less than or equal to 5.92 
Remote  CDs with an average ARIA index value greater than 5.92 and less than or equal to 10.53 
Very remote CDs with an average ARIA index value greater than 10.53 
Migratory  Areas composed of off-shore, shipping and migratory CDs 
Women were allocated to a remoteness area using their residential postcode supplied at the 
time of screening. Caution is required when examining differences across remoteness areas. 
First, postcodes used to allocate women may not represent their location of residence. 
Second, because remoteness area classifications are based on the 2006 Census, their accuracy 
diminishes due to subsequent changes in demographics. Third, many postcodes (and hence 
women) are unable to be allocated to a remoteness area. 
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Socioeconomic status 
Socioeconomic status classifications are based on the ABS Index of Relative Socioeconomic 
Disadvantage (ABS 2008). Geographic areas are assigned a score based on attributes such as 
low income, low educational attainment, high unemployment and jobs in relatively 
unskilled occupations. The score does not refer to the socioeconomic situation of a particular 
individual but instead refers to the geographic area in which a person lives. A low score 
means an area has many low-income families, people with little training and high 
unemployment, and may be considered disadvantaged relative to other areas. Areas with 
high index scores may be considered less disadvantaged relative to other areas.  
Socioeconomic status groups based on the level of the index are used for analysis where 
1 (lowest) represents the most disadvantaged and 5 (highest) the least disadvantaged. 
Women were allocated to a socioeconomic status using their residential postcode supplied at 
the time of screening. Caution is required when examining differences across socioeconomic 
status for several reasons. First, postcodes used to allocate women may not represent their 
location of residence. Second, because socioeconomic status classifications are based on the 
2006 Census, their accuracy may diminish due to subsequent changes in demographics. 
Third, many postcodes (and hence women) are unable to be allocated to a socioeconomic 
status group. 
BreastScreen Australia classifications 
See Appendix B, ‘BreastScreen Australia definitions’ for classifications specific to 
BreastScreen Australia. 
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Appendix D BreastScreen Australia  
2010–2011 Data Quality Statement 
Summary of key data quality issues 
• All states and territories maintain a population-based BreastScreen register which 
records the data collected during a woman’s contact with a BreastScreen service.  
• The AIHW compiles BreastScreen Australia data supplied from state and territory 
BreastScreen registers in order to monitor BreastScreen Australia annually at a national 
level.  
• State and territory BreastScreen registers change every day, adding new records and 
improving the quality of existing records as new information becomes available. 
BreastScreen Australia data may therefore change.  
• Some New South Wales data were not available for inclusion in the BreastScreen 
Australia monitoring report 2009–2010. (See the BreastScreen Australia 2009–2010 Data 
Quality Statement for more information). These data have since been provided.  
• Data for all jurisdictions were available for 2010–2011.  
Description  
BreastScreen Australia is Australia’s national, population-based breast cancer screening 
program and is a joint program of the Australian and state and territory governments.  
BreastScreen registers in each state and territory record data collected during a woman’s 
contact with a BreastScreen service. 
Each BreastScreen program supplies BreastScreen data annually to the AIHW. These data are 
compiled into the BreastScreen Australia database, held at the AIHW to enable national 
monitoring of BreastScreen Australia. 
Some BreastScreen data are supplied as aggregate data, which are not included in the 
BreastScreen Australia database. 
Institutional environment  
The AIHW is a major national agency set up by the Australian Government under the 
Australian Institute of Health and Welfare Act 1987 (Cwlth) to provide reliable, regular and 
relevant information and statistics on Australia’s health and welfare. It is an independent 
statutory authority established in 1987, governed by a management Board, and accountable 
to the Australian Parliament through the Health and Ageing portfolio. 
The AIHW aims to improve the health and wellbeing of Australians through better health 
and welfare information and statistics. It collects and reports information on a wide range of 
topics and issues, ranging from health and welfare expenditure, hospitals, disease and 
injury, and mental health, to ageing, homelessness, disability and child protection. 
The Institute also plays a role in developing and maintaining national metadata standards. 
This work contributes to improving the quality and consistency of national health and 
welfare statistics. The Institute works closely with governments and non-government 
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organisations to achieve greater adherence to these standards in administrative data 
collections to promote national consistency and comparability of data and reporting. 
One of the main functions of the AIHW is to work with the states and territories to improve 
the quality of administrative data and, where possible, to compile national data sets based on 
data from each jurisdiction, to analyse these data sets and disseminate information and 
statistics. 
The Australian Institute of Health and Welfare Act 1987, in conjunction with compliance to the 
Privacy Act 1988 (Cwlth), ensures that the data collections managed by the AIHW are kept 
securely and under the strictest conditions with respect to privacy and confidentiality. 
For further information see the AIHW website <www.aihw.gov.au>. 
The AIHW has been receiving BreastScreen data since 1996. 
Timeliness  
BreastScreen data are available within about 6–12 months of activity (t can take up to 12 
months for final pathology results on all breast tissue samples to be received by BreastScreen 
registers.) The BreastScreen Australia database cannot be fully compiled until the final 
jurisdiction supplies its data. 
Participation data for the previous calendar year are supplied in July each year; rescreening 
and invasive breast cancer and DCIS detection data for the previous calendar year are 
supplied July–December each year. (Rescreening and sensitivity data lag behind, as the 
specifications for these require a specified period of time to pass before they can be 
accurately calculated.) 
The current BreastScreen Australia database contains data on women who participated in 
BreastScreen Australia between 1996 and 2011. 
Accessibility  
BreastScreen Australia data are published annually in the BreastScreen Australia monitoring 
report available on the AIHW website <http://www.aihw.gov.au/breast-cancer-screening/> 
where they can be downloaded without charge. Supplementary data tables presenting more 
detailed data accompany each report and these, too, are available on the AIHW website 
where they can be downloaded without charge. 
General enquiries about AIHW publications can be made to the Communications, Media and 
Marketing Unit on (02) 6244 1032 or via email to <info@aihw.gov.au>. 
Interpretability  
While many concepts in the BreastScreen Australia monitoring report are easy to interpret, 
other concepts and statistical calculations are more complex. All concepts are explained 
within the body of the report presenting these data, along with footnotes to provide further 
details and caveats. The appendixes provide additional detail on the data sources and 
classifications, and on the statistical methods used. 
Relevance  
Breast cancer screening data are highly relevant for monitoring trends in breast screening 
participation and the detection of invasive breast cancer and DCIS, as well as other measures 
of program performance such as recall rates and sensitivity measures. The data are used for 
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many purposes by policy makers and researchers, but are supplied and analysed specifically 
to monitor and inform BreastScreen Australia. 
Accuracy 
All data provided by state and territory BreastScreen programs, once analysed, are supplied 
back to the jurisdictional BreastScreen programs for verification. 
Women attending a BreastScreen service are able to self-report Indigenous status; this 
database field is therefore considered to be of high quality. However, use of the ‘not stated’ 
category has changed substantially over time, which makes trend data difficult to interpret. 
State and territory BreastScreen databases change every day, and not just because new 
records are added; existing records are changed if new, more precise information becomes 
available or if typographical errors are discovered by routine data checking procedures. As a 
result, the number of women participating, as well as DCIS and invasive breast cancer cases 
reported by the AIHW for any particular year, may change slightly over time. Further, data 
published by a jurisdictional BreastScreen program at a certain point in time may differ 
slightly from what is published by the AIHW at a different time. 
Coherence  
BreastScreen data are reported and published annually by the AIHW.  
Some New South Wales data were not available for inclusion in the BreastScreen Australia 
monitoring report 2009–2010. (See the BreastScreen Australia 2009–2010 Data Quality 
Statement for more information.) These data have since been provided. Data for all 
jurisdictions were available for 2010–2011.   
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Appendix E Statistical methods 
Comparisons and tests of statistical significance 
This report includes statistical tests of the significance of comparisons of rates between 
population groups. Any statistical comparison applied to one variable must take account of 
any other potentially relevant variables. For example, any comparison of participation by 
state must also take account of differences in the distribution of age between the states. These 
other variables are known as ‘confounding’ variables. 
Crude rates 
A crude rate is defined as the number of events over a specified period of time (for example, 
a year) divided by the total population. For example, a crude cancer incidence rate is defined 
as the number of new cases of cancer in a specified period of time divided by the population 
at risk.  
Crude mortality rates and cancer incidence rates are expressed in this report as number of 
deaths or new cases per 100,000 population. Crude participation rate is expressed as a 
percentage. 
Age-specific rates 
Age-specific rates are calculated by dividing the number of cases occurring in each specified 
age group by the corresponding population in the same age group, expressed as a 
percentage or a number per 1,000 or 100,000 population. This rate may be calculated for 
particular age and sex groupings.  
For example: 
Age-specific cervical cancer incidence rate in females aged 50–54:  
= (New cases aged 50–54 over Female population aged 50–54) times 100,000 
= (75 over 698,700) times 100,000 
= 10.7 per 100,000 
Age-standardised rates  
Rates are adjusted for age to facilitate comparisons between populations that have different 
age structures; for example, between youthful and ageing communities. There are two 
different methods commonly used to adjust for age.  
This publication uses direct standardisation, in which the age-specific rates are multiplied by 
a constant population (the 2001 Australian Standard Population, unless otherwise specified). 
This effectively removes the influence of the age structure on the summary rate. 
It important to note that, for some data presented in this report, indirect age standardisation 
would be more appropriate due to small numbers (most commonly for the Australian 
Capital Territory and the Northern Territory); however, direct age standardisation has been 
used for consistency. This can result in relatively large differences between crude and 
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age-standardised rates. In these cases, crude rates should also be considered when 
interpreting data. 
The method used for this calculation is as follows: 
  First, the age-specific rate is calculated (as shown above) for each age group.  
 Second, the expected number of cases in each 5-year age group is calculated by 
multiplying the age-specific rates by the corresponding standard population and 
dividing by the appropriate factor (that is, 100,000 for mortality and incidence rates, and 
100 for participation).  
 Third, to give the age-standardised rate, the expected number of cases in each group are 
summed, divide by the total of the standard population and multiplied by the 
appropriate factor (for example, 100,000 for mortality and incidence rates, and 100 for 
participation). 
Confidence intervals 
Population numbers for incidence and mortality and screening have a natural level of 
variability for a single year above and below what might be expected in the mean over many 
years. The percentage variability is small for large population numbers but high for small 
numbers such as mortality in a young age group. One measure of the likely difference is the 
standard error, which indicates the extent to which a population number might have varied 
by chance in only 1 year of data. In the 95% confidence interval, there are about 19 chances in 
20 that the difference will be less than two standard errors. 
There are several methods for calculating confidence intervals. The 95% confidence intervals 
in this report were calculated using a method developed by Dobson et al. (1991). This 
method calculates approximate confidence intervals for a weighted sum of Poisson 
parameters. 
Interpretation of confidence intervals 
Where indicators include a comparison (such as between states and territories), a 95% 
confidence interval is presented along with the rates. This is because the observed value of a 
rate may vary due to chance, even where there is no variation in the underlying value of the 
rate. The 95% confidence interval represents a range (interval) over which variation in the 
observed rate is consistent with this chance variation. In other words, there is a 95% 
confidence that the true value of the rate is somewhere within this range. 
These confidence intervals can be used as a guide to whether differences in a particular rate 
are consistent with chance variation. Where the confidence intervals do not overlap, the 
difference between rates is greater than that which could be explained by chance and is 
regarded as being statistically significant at the 95% level. 
It is important to note that overlapping confidence intervals does not imply that the 
difference between two rates is definitely due to chance. Instead, an overlapping confidence 
interval represents a difference in rates that is too small to allow differentiation between a 
real difference and one that is due to chance variation. It can, therefore, be stated only that no 
statistically significant differences were found, and not that no differences exist. 
The approximate comparisons presented might understate the statistical significance of some 
differences, but they are sufficiently accurate for the purposes of this report. 
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As with all statistical comparisons, care should be exercised in interpreting the results of the 
comparison. If two rates are statistically significantly different from each other, this means 
that the difference is unlikely to have arisen by chance. Judgment should, however, be 
exercised in deciding whether or not the difference is of any clinical significance. 
Small counts 
Numbers of 1 and 2 as well as the rates on which these are based have been suppressed. 
(Some small numbers remain in some indicators, where these were considered important to 
show.) Additional suppression has been applied to some data on the request of the data 
custodians. 
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Glossary 
Aboriginal or Torres Strait Islander: a person of Aboriginal and/or Torres Strait Islander 
descent who identifies as an Aboriginal and/or Torres Strait Islander. 
Age-specific rate: a rate for a specific age group. The numerator and denominator relate to 
the same age group. 
Age-standardised rate: a method of removing the influence of age when comparing 
populations with different age structures. This is usually necessary because the rates of many 
diseases vary strongly (usually increasing) with age. The age structures of the different 
populations are converted to the same ‘standard’ structure, which allows comparison of 
disease rates.  
Assessment: further investigation of a mammographic abnormality or symptom reported at 
screening.  
Benign: not malignant. 
Biopsy: small sample of tissue that is taken to obtain a definitive diagnosis of an 
abnormality. 
Cancer (malignant neoplasm): a term used to describe one of several diseases that result 
when the process of cell division, by which tissues normally grow and renew themselves, 
becomes uncontrolled and leads to the development of malignant cells. These cancer cells 
multiply in an uncoordinated way, independently of normal growth control mechanisms, to 
form a tumour. The tumour can expand locally by invasion or systemically by metastasis 
through the lymphatic or vascular systems. If left untreated, most malignant tumours 
eventually result in death. 
Cancer death: a death where the underlying cause is indicated as cancer. People with cancer 
who died of other causes are not counted in the death statistics in this publication. 
Confidence interval: a range determined by variability in data, within which there is a 
specified (usually 95%) chance that the true value of a calculated parameter lies. 
Data: the building blocks of health information, including observations from administrative 
databases and health survey data sets. 
Ductal carcinoma in situ: a non-invasive tumour of the mammary gland (breast) arising 
from cells lining the ducts. 
False negative: a test that has incorrectly observed that the disease is not present. 
False positive: a test that has incorrectly observed that the disease is present. 
First screening round: see Screening round. 
ICD-10: International Classification of Diseases – a coding system used to identify the 
primary site of the malignancy. This classification is in its 10th revision. 
in situ: a Latin term meaning in place or position; undisturbed. 
Incidence: see New cancer case. 
Incident cancer: a new cancer that is detected in a subsequent screening round. 
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Index screening year: the year for which the interval cancer rate and the program sensitivity 
rate are determined. 
Index screens: all screening examinations performed within the index screening year. 
Indicators: observations about data that have been analysed to provide a means of 
comparing measures of health within and between population groups. 
International Classification of Diseases: the World Health Organization’s internationally 
accepted classification of diseases. The 10th revision (ICD-10) is currently in use. 
Interval cancer—invasive (as defined for national reporting purposes by Kavanagh et al. 
1999, with minor changes endorsed by the National Advisory Committee): 
• an invasive breast cancer diagnosed after completion of a negative screening episode 
and before the next screening examination (within 24 months from the date of the 
previous screen) 
• a case of invasive breast cancer that is diagnosed at early review or in the interval 
between assessment and early review, where the recommendation for early review is 
6 months or more from the screening date 
• breast cancer diagnosed in a woman by BreastScreen Australia within 24 months of a 
negative screen (early rescreen) if the woman presents with a breast lump and/or clear 
or blood-stained nipple discharge in the breast in which the breast cancer was diagnosed 
• an invasive breast cancer diagnosed between 6 and 24 months after a recommendation 
for assessment is made and a woman fails to attend assessment. 
Invasive cancer: a tumour whose cells have the potential to spread to nearby healthy or 
normal tissue or to more distant parts of the body. 
Malignant: abnormalities in cells or tissues consistent with cancer.  
Mammogram: a radiographic depiction of the breast. 
Metastasis: the process by which cancerous cells are transferred from one part of the body to 
another, for example, via the lymphatic system or the bloodstream. 
Morbidity: illness. 
Mortality: see Cancer death. 
New cancer case: a person who has a new cancer diagnosed for the first time. One person 
can have more than one cancer and therefore may be counted twice in incidence statistics if it 
is decided that the two cancers are not of the same origin. This decision is based on a series 
of principles set out in more detail in a publication by Jensen et al. (1991). 
Population estimates: official population numbers compiled by the ABS at both state and 
territory and statistical local area levels, by age and sex, as at 30 June each year. These 
estimates allow geographic areas of differing population sizes and age structures to be 
compared. 
Prevalent cancer: an existing cancer that is detected at a woman’s first screen. 
Rescreening: the next screening examination after the screening episode in the index 
screening year. 
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Risk factor: an attribute or exposure that is associated with an increased probability of a 
specified outcome, such as the occurrence of a disease. Risk factors are not necessarily the 
causes of disease. 
Screening: the performance of tests on apparently well people in order to detect a medical 
condition at an earlier stage than would otherwise be the case. Because a screening test is not 
intended to be diagnostic, a person with a positive or suspicious result must be referred for 
diagnosis and treatment if necessary. 
Screening episode: all attendances for screening and assessment within 6 months relating to 
a particular round of screening. It starts at the date of attendance for screening. It is 
completed when: 
• a recommendation is made to return the woman to routine rescreening 
• a recommendation is made for early review at 6 months or more from the screening date 
• a diagnosis of cancer is made 
• the woman fails to attend for technical recall or assessment within 6 months 
• the woman dies. 
Screening round: the first screening round is a woman’s first visit to a mammography 
screening service; a subsequent screening round means that she has been screened before. If 
she attends for the fourth screening round, she has been screened three times before. 
Screening round (first): a woman’s first visit to a BreastScreen Australia mammography 
screening service. 
Screening round (subsequent): a woman’s visit to a BreastScreen Australia mammography 
screening service when she has attended such a service before. 
Sensitivity: the proportion of people with a disease that has a positive test result for the 
disease. 
Significant difference: a difference between rates deemed to be statistically significantly 
different. This occurs when their confidence intervals do not overlap, because their 
difference is greater than what could be explained by chance. See ‘confidence intervals’ in 
Appendix D for more information. 
Symptom: any evidence of disease apparent to the patient. For the purposes of this report, 
symptoms refer to a self-reported breast lump and/or blood-stained or watery nipple 
discharge. 
Target population: women aged 50–69. 
Tumour: an abnormal growth of tissue. Can be benign (not a cancer) or malignant (cancer).  
The Institute: the Australian Institute of Health and Welfare. 
Ultrasound: diagnostic method based on the reflection of ultrasonic sound waves generated 
through scanning of, in this case, the breast. The reflections are viewed on a computer screen 
or photograph and checked for variations in images. 
Underlying cause of death: the condition, disease or injury initiating the sequence of events 
leading directly to death; that is, the primary, chief or principal cause.  
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Women-years ‘at risk’ of interval or screen-detected breast cancer are: 
• all women screened aged 50–69 who are resident in the service catchment area in which 
they are screened at the time of screening who have not reported a personal history of 
invasive cancer or DCIS 
• women who are recommended for annual rescreening are only at risk of interval cancer 
until 12 months after the screening examination 
• women who are recommended for routine rescreening are only at risk of an interval 
cancer until 24 months after the screening examination. 
 
Note: terms in italics are defined elsewhere in the glossary. 
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